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Summary 
Maggot debridement therapy (MDT) is an U.S. Food and Drug Administration (FDA) as well as 
European Medicines Agency (EMA) approved treatment for various chronic and recalcitrant wounds. 
MDT was successfully applied in numerous case studies (Sherman 2002; Sherman 2003) and shown to 
have beneficial effects on wound debridement, disinfection and hastened healing processes (Sherman 
2014). Larval secretions and excretions (E/S) represent a complex mixture of enzymes, AMPs and small 
molecules and as such serves as a rich source of new therapeutics (Sherman 2014). Unfortunately, the 
complexity of this mixture makes it very hard to decipher the exact roles and benefits of individual 
components in the wound healing process and requires more detailed studies (Davydov 2011). 
This thesis is based on two parts. The first part, published in PLOS ONE (Baumann et al. 2015), focused 
on the establishment of a qRT-PCR approach by investigating tissue specific expression stability of 10 
candidate reference genes in immune challenge experiments. Quantitative RT-PCR serves as a golden 
standard in the field of gene expression (Bustin et al. 2009; Nolan et al. 2006) and its establishment in 
L. sericata serves as an important tool for identification and validation of genes involved in maggot 
therapy. My study shows that the combination of three reference genes RPLP0, EF1α and RPS3 provides 
reliable normalization of L. sericata expression data among all tested samples, thus allowing for the first 
time the precise normalization of gene expression in larval tissues involved in production of E/S. The 
methods of tissue sample preparation and gene expression analysis established during this thesis also 
contributed to Beckert et al. (2015) and Beckert et al. (2016). Reference genes were applied in Pöppel et 
al. (2016) and Franta et al. (2016). 
Second part of this thesis, submitted to Insect Biochemistry and Molecular Biology (Baumann et al. 
2016), focuses on recombinant production and characterization  of L. sericata Urate Oxidase (UO) an 
enzyme that exclusively creates allantoin, which contributes to the wound healing process (Araujo et al. 
2010; DiSalvo 2002). I was the first to produce and characterize an insect UO. Recombinant UO was 
produced using E. coli expression system, purified via IMAC (denaturing chromatography), refolded 
and tested for its pH optimum (in the alkaline), temperature optimum (20-25 °C), competitive inhibition 
(typical for UO), cofactors (cofactor independent) and stability (short shelf life). Furthermore, I 
monitored the presence of L. sericata UO on mRNA as well as protein level in various L. sericata tissues 
and showed that both UO gene as well as native UO localize predominately inside Malpighian tube cells 
sharing strictly cytosolic localization. Based on these data it can be assumed that allantoin is produced 
by UO to remove uric acid from the insect hemolymph by the Malpighian tubes and is excreted via the 
hindgut as nitrogenous waste product. Those findings support the hypothesis that not only actively 
secreted molecules, but also excretion products contribute to the beneficial effects of MDT.
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1. Introduction 
Insects are the biggest and the most diverse animal class on earth representing more than 70 % of all 
known species (Figure 1; (Chapman 2009)). With more than 1 million species described (Groombridge 
and Jenkins 2002) and 5-6 million estimated in total (Raven and Yeates 2007) only a small fraction of 
insects variety is recognized so far. Insects are the most successful terrestrial colonizers on Earth and can 
be found everywhere around the globe surviving under harshest conditions. The Antarctic midge Belgica 
antarctica can withstand the extreme cold in Antarctica and is the largest land animal living there the 
whole year (Lee et al. 2006). 
 
Figure 1: Animal species infographics according to Chapman (2009). 
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The Sahara Desert ant Cataglyphis bicolor can permanently withstand temperatures above 50 °C, which 
makes it the only land animal capable of surviving such an extreme heat (Sherwood 1996). In addition 
to extreme conditions such as temperature or high salinity levels, there are insects like the larvae of 
Eristalis tenax (Jacobs and Renner 2007) that live and feed in places with high bacterial load like 
cesspools or sewages. Taken together, remarkable resilience and biodiversity make insects the rich 
source of molecules with medical and/or biotechnological potential. 
Insects’ enormous adaptability and ability to overcome severe conditions was recognized by different 
human cultures centuries ago. Various insect species as well as their secretions, venoms but also their 
products (e.g. honey) became a part of the traditional medicines and are recently reevaluated as a rich 
source of therapeutic molecules for modern western medicine (Cherniack 2010) with L. sericata maggots 
and honey bees as the vanguard of this field. Many clinical trials proved the beneficial effects and healing 
potential of insect compounds (McIntosh and Thomson 2006; Steenvoorde et al. 2007). Among others 
honey is used for treatment of burns (Subrahmanyam 1991) or ant venoms for treatment of rheumatoid 
arthritis (Altman et al. 1984). Furthermore as a direct live animal application L. sericata maggots are 
used as an alternative treatment for chronic and recalcitrant wounds that is nowadays known as maggot 
debridement therapy (MDT) (Sherman 2014). In addition, the investigation of insect scavengers such as 
blowflies (e.g. L. sericata) is exploited in forensic entomology to estimate the time of the death on a 
crime scene. There the postmortem interval of a corpse is determined by calculating the age of immature 
insect stages feeding on a corpse as well as by analyzing the exact species present. By this the postmortem 
intervals of a dead body can be estimated ranging from day one up to several weeks (Amendt et al. 2004). 
The detailed understanding of insect anatomy, life-cycle and way of life is the crucial to unlock the full 
potential of various insect like L. sericata for bio-applications e.g. in medicine or forensic entomology. 
 
1.1. Lucilia sericata 
1.1.1. Taxonomy 
The green bottle fly Lucilia sericata (Meigen, 1826) represents the exclusive species in MDT. It belongs 
to the class Insecta and the order Diptera (Figure 2A). The term originates from the Greek di = two and 
ptera = wings) (Honomichl 2010). Order Diptera consist of more than 100 000 described species and its 
members are typified by only a single set of functional wings (forewings), while the second pair of wings 
(hindwings) evolved into halters a knob-shaped sensory organs, which monitor body rotation during the 
flight (Wendler 2010). The family Calliphoridae commonly known as blowflies consist of about 1100 
species and includes many important parasitic species, but also pollinators that are attracted by plants 
resembling the odors of rotten meat (Willemstein 1987). 
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Figure 2: Lucilia sericata A: L. sericata taxonomy. B: Adult L. sericata (green blowfly) (“Green_bottle_fly3.jpg“ 
Calibas is licensed under CC-BY-SA 4.0). 
 
Flies from the genus Lucilia commonly share the metallic blue or green-golden color (Figure 2B) which 
develops once the cuticle of the freshly emerged adult stretches, dries and hardens. All members of this 
genus feed on animal tissues or feces, but differ in their prevalence for necrotic tissue as well as in the 
antimicrobial properties of their secretions (Grassberger et al. 2013). To distinguish between L. sericata 
and other closely related species of the genus Lucilia, the precise investigation of various morphological 
parameters like femur color, numbers of paravertical setulae or width of the frontal stripe (Williams and 
Villet 2014). Those small details are important while choosing the right insect for the treatment or 
coming to the correct conclusion at the crime scene. An alternative to the morphological identification 
are genetic analysis of molecular markers that can also identify Lucilia hybrids (Stevens and Wall 1996). 
1.1.2. Life-cycle 
The L. sericata life-cycle consists of  4-stages including egg, larva, pupa and adult (Eggert et al. 2010). 
Adult L. sericata females lay up to 200 eggs on dead and/or decaying tissues, open wounds or feces. The 
female places eggs by unfolding her ovipositor and laying (“blowing”) the eggs onto the food source, 
which led to the name blowfly. One female can produce up to 3000 eggs during her lifetime (Fleischmann 
et al. 2004). 1st Instar larvae hatch after 8-24 h depending on the external temperature. 2nd and 3rd instar 
larvae molt and shed their undersized cuticle within the next 4-7 days, but this is highly dependent on 
several exogenous factors like temperature, food quality or quantity of the larvae. Fed 3rd instar larvae 
crawl away from the food source and search for a dark and humid place to enter the pupal stage 
(Grassberger et al. 2013). During pupation, which lasts 10-20 days the larvae transform (metamorphoses) 
and emerge as an adult fly (Figure 3). The life span of the adult is around 1–2 months. L. sericata has a 
seasonal activity peaking during the warmer period of the year from May to October, which can lead to 
up to eight generations of flies (Fleischmann et al. 2004). 
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Figure 3: The life-cycle of L. sericata. Designed by and courtesy of Dr. Henrike Schmidtberg. 
1.1.3. Anatomy 
In maggot therapy only the 1st instar larvae are applied to the wound bed. The larval body is simple and 
exhibits few organs (salivary glands, crop, gut, Malpighian tubes, fat body, nerve ganglion and trachea). 
It is optimized for the uptake of large amounts of food. In five minutes a larva can ingest an amount of 
food reaching almost the half of its body weight and due to this larva can increase its weight 100 times 
in the first 72 h after hatching (Grassberger et al. 2013). The larvae have a pair of mouth hooks, which 
facilitate larval movement and in addition tears the tissue apart thus easing digestive enzymes to sink in  
(Figure 4) (Fleischmann et al. 2004). Larvae perform extracorporeal digestion. They secrete various 
digestive enzymes into the wound to liquefy/predigest the tissue, which is subsequently ingested. Many 
of these digestive enzymes which are predominantly produced in the salivary glands are a promising 
target for further investigations. The very flexible crop serves as a short-term food storage e.g. to provide 
food during migration of pupation. The enzymatically liquefied tissue is sucked in and concentrated up 
to 5 time in the proventriculus before it reaches the midgut (Grassberger et al. 2013). 
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Figure 4: Maggot anatomy. Designed by and courtesy of Dr. Henrike Schmidtberg. 
The food is further processed in the midgut by digestive enzymes, bacteria are here eliminated and 
nutrients are absorbed by the gut walls, therefrom they pass over into the hemolymph. The intersection 
between the thick midgut and the thinner hindgut is easily distinguishable by the Malpighian tubes 
connection. These single cell layer tubes serve as drainage pipes and filter excretion products from the 
hemolymph while keeping the osmotic pressure (Peters 2010). Excretion products are further processed 
and emptied into the hindgut where they mix with partially digested food coming from the midgut. In 
the hindgut further breakdown of excretion products and nutrition uptake takes place before the final end 
products are excreted over the anus while keeping liquid and ion balance. The fat body has no direct 
involvement in digestion. Fat body cells encase most organs and are surrounded by hemolymph. They 
carry out multiple metabolic functions like energy storage in the form of glycogen, lipid storage and they 
are also the major tissue for internal immune defense that facilitates the rapid production of the AMPs 
arsenal (Peters 2010).The nerve ganglion located in the head part is the central nerve cluster of the 
maggot (Milde 2010). The trachea system of air-filled tubes spans the whole larvae and provides oxygen 
directly to the tissues. The air exchanges through the two respiratory stigmata located on the back part 
of the maggot above the anus (Wasserthal 2010). L. sericata Larvae are remarkable microsurgeons that 
liquefy and remove wound material without damaging the healthy tissue. This surgical ability together 
with combination if both external and internal bacteria elimination make L. sericata larvae a valuable 
tool for treatment of chronic wounds. Thus a deeper understanding of  maggot anatomy and behavior 
can strongly enhance their biotechnological application (Fleischmann et al. 2004).  
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1.2. Chronic wounds 
Maggots that feed on necrotic and decaying tissue have been shown to be beneficial in the treatment of 
chronic human wounds. Wound healing is a crucial, life-maintaining process, which can be divided into 
4 overlapping phases: (I) hemostasis, (II) inflammation, (III) proliferation and (IV) maturation. In this 
highly complex process many cells and mediators interact in a well-orchestrated manner that is still not 
completely understood. Immediately after injury (I) hemostasis is triggered to stop blood loss. The (II) 
inflammation phase (day 0-6) is initiated to clear the wound from all the foreign material including 
bacteria and necrotic tissue. Once the wound is cleaned (III) the proliferative phase (day 4-14) is initiated 
to close the wound and finally (IV) the maturation phase (starting day 8, but can take up to a year) leads 
to tissue remodeling (Broughton et al. 2006). 
A chronic wound is defined as a wound that does not reach the final maturation phase within 12 weeks. 
In such wounds the transition between the healing phases is impaired and most of them are stuck in the 
inflammatory phase. They are characterized by the presence of necrotic and infected tissue, which was 
not removed adequately and show only weak immune response due to the disconnection from the blood 
stream (Eming et al. 2007). Such an environment, rich in nutrition and lacking any immune defense, 
offers ideal growth conditions for many microorganisms including pathogenic strains (Dow et al. 1999). 
Pressure ulcers (~20 % of all hospital patients across Europe (Vanderwee et al. 2007)) and diabetic foot 
ulcers with a lifetime risk of 15 % (60 million diabetics across Europe) (Jeffcoate and Harding 2003) are 
prominent among chronic and recalcitrant wounds. In chronic wounds with a high bacterial population 
the use of systemic antibiotics is challenging, because the wound is often disconnected from the 
bloodstream (Hernandez 2006). Topical antibiotics often show now effect, because the bacteria are 
protected by biofilm or feature a resistance (e.g. Methicillin-resistant Staphylococcus aureus (MRSA)) 
(Attinger and Wolcott 2012; Howell-Jones et al. 2005). In such severe cases surgery is inevitable. For 
diabetic foot ulcers standard treatment often involves extensive surgery as well, which leads in 15 % of 
all cases to the amputation of a toe, foot or leg. Surgical removal of the necrotic tissue results in 
enlargement of the wound bed as well as in hard bleeding and direct damage of healthy tissue (Thomas 
2006). Post surgery the wound is covered by a dressing (e.g. hydrogel), which normally does not increase 
the healing rate, but should offer ideal conditions for healing. Those post surgical wounds are highly 
susceptible to bacterial infections and thus need to be kept sterile and under careful supervision (Yao et 
al. 2013). In an aging population treatment of chronic wounds requires costly intensive care reaching to 
2-4 % of total EU health care expenses (Posnett et al. 2009; Sen et al. 2009), but also causes severe 
emotional and psychical stress to patients and as such create a demand for new alternatives. 
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A promising alternative treatment for many chronic wounds that reemerged over the last 20 years is 
maggot debridement therapy (MDT). MDT can be defined as an artificially induced myasis, which is 
carefully controlled. Fly larvae, applied to the wound bed, debride more precisely than any surgeon (only 
the necrotic tissue) resulting in no increase of the wound bed and almost no bleeding. Moreover, larvae 
alone or in combination with antibiotics (Sherman 2009) were also shown to degrade bacterial biofilms 
and eliminate a wide range of pathogens including multi-resistant strains like MRSA (Bexfield et al. 
2008). MDT exhibit not only remarkable direct effects on wound healing but is also important from the 
economic point of view. It has been shown to hastened healing properties, thus reducing the hospital 
time and associated costs amounting up to 80 % of conventional chronic wound treatment (Church 1996). 
 
1.3. Maggot debridement therapy (MDT) 
Fly maggots have been known to positively influence the wound healing for centuries. First reports can 
be found from Australian Aborigines (Dunbar 1944) and Mayas (Weil et al. 1933). Various military 
surgeons observed that maggots populate wounds and written reports date back to the 16th century when 
Ambroise Paré noted the remarkably quick recovery of maggot-infested patients. Paré was not attributing 
this to the maggots or even comprehended those were fly larvae (Goldstein 1931). Baron Dominique-
Jean Larrey a surgeon in Napoleon’s army recognized the maggot’s prevalence for necrotic tissue and 
the accelerated healing properties, but did not actively apply them (Larrey 1829). The first direct 
application came during the American Civil War, when Confederate surgeon John Forney Zacharias 
lacking supply of conventional dressing material used maggots as an alternative (Chernin 1986). US 
podiatrist, William S. Bear made his observations on maggots during the First World War and utilized 
his experience later as a professor at the John Hopkins University in the treatment of chronic 
osteomyelitis (Whitaker et al. 2007). He is the founding father of modern MDT by introducing maggot-
dressings and the use of sterile larvae in treatments. Ultimately he convinced the skeptic scientific 
community and in the 1930s maggots were used in over 300 hospitals across the US and Europe. The 
hospitals that did not rear their own sterile maggots could buy commercial produced ones distributed as 
“Surgical Maggots-Lederle”. The discovery and marketing of penicillin in 1940th together with improved 
surgical knowledge in wound care after the Second World War shifted the focus from maggot therapy 
towards the use of antibiotics. The popularity of mostly penicillin resulted in the rapid decline of MDT, 
which was considered as an old fashion method (Fleischmann et al. 2004). The renaissance of MDT 
came at the end of the 20th century, intractable wounds still represent a challenge for modern medicine. 
The antimicrobial and debridement properties of maggots let maggot therapy re-emerge as an alternative 
therapeutic approach (Figure 5) (Grassberger et al. 2013; Sherman et al. 2000). 
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Figure 5: History of maggot therapy. According to Fleischmann et al. (2004), designed by and courtesy of Dr. Anne 
Pöppel. 
 
Modern maggot debridement therapy (MDT) is based on Bears method and underpinned by clinical 
studies starting in the 1990s (Sherman et al. 1995) that significantly improved our knowledge about the 
benefits of MDT. Its superb debridement together with decreased risk of post-surgery infections 
(Sherman 2002; Sherman 2003; Sherman et al. 2001) led to its approval by the U.S. Food and Drug 
Administration (FDA; case number K033391) as a medical device in 2004. Nowadays MDT is a popular 
alternative treatment for chronic and recalcitrant wounds. The prime FDA approved species for MDT 
are maggots of the green bottle fly Lucilia sericata. They are the first live animal treatment approved by 
the FDA. In Europe the European Medicines Agency (EMA, case number EMEA-000714-PIP01-09) 
approved L. sericata maggots in 2010 only for leg ulcers in the Biobag format. In Germany L. sericata 
maggots are a prescription drug since 2014 (http://www.kbv.de/html/11710.php). During MDT maggots 
have 3 modes of action. They contribute to wound debridement (I), disinfection (II) and hastened healing 
process (III). Those are mediated by secretions and excretions (E/S) consisting of various compounds 
including enzymes, antimicrobial peptides (AMPs) and small molecules as well as by physical properties 
of the maggot itself (Figure 6) (Sherman 2014). In this complex multi-stage process many components 
work synergistically together. In consequence it is still challenging to understand many key mediators 
on a molecular level. 
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Figure 6: Overview of proven and postulated mechanisms by which medical maggots promote wound healing  from
Sherman (2014) published by Hindawi, licensed under CC BY 4.0. 
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Removal of necrotic tissue and foreign material known as debridement (I) is crucial to promote the 
healing process of any chronic wound (McCallon et al. 2014). MDT represents a safe and efficient 
therapy which substantially contribute to wound bed debridement (Gottrup and Jorgensen 2011). Maggot 
E/S contain various enzymes including proteases (Chambers et al. 2003; Valachova et al. 2014) and 
nucleases (Brown et al. 2012), which debride the wound bed by liquefying the necrotic tissue 
(extracorporeal digestion) for subsequent larval ingestion. Three classes of proteolytic enzymes (serine-, 
aspartic- and metalloproteases) have been identified using class specific substrates and inhibitors in E/S 
(Chambers et al. 2003). The serine proteases (trypsin-like and chymotrypsin-like) showed predominant 
activity with a pH optimum of 8-9. Aspartic proteases showed an optimum around pH 5 and 
metalloproteases around pH 9. Recently, proteases belonging to five different clans (cysteine, aspartic, 
threonine, serine and metalloprotease) have been shown to be differentially expressed in various larval 
tissues (Franta et al. 2016). While moving in the wound bed the mouth hooks and spicules on the larval 
body rasps the tissue and facilitate the entry of proteolytic enzymes. Although maggot E/S represent a 
rich source of therapeutic proteases, until recently, only two (both serine proteases) have been produced 
recombinantly and evaluated for their medical potential. The chymotrypsin produced by Telford et al. 
(2010) was shown to degrade proteins from slough of venous leg ulcers. The Jonah-like chymotrypsin 
produced by Pöppel et al. (2016) was shown to reduce clotting time of human plasma as well as to cleave 
extracellular matrix proteins (fibronectin, laminin, collagen IV). Recently a serine protease sequence has 
been patented under the name debrilase for its ability to support wound debridement (Patent publication 
number US20120093788 A1). 
Disinfection (II) represents another well-described effect of MDT. Larvae contribute to wound cleansing 
by secretion of a diverse spectrum of AMPs (Altincicek and Vilcinskas 2009; Cerovsky and Bem 2014; 
Pöppel et al. 2014; Pöppel et al. 2015) and small molecules (Bexfield et al. 2008; Huberman et al. 2007a; 
Huberman et al. 2007b) as well as by the direct ingestion of microbes and their elimination within the 
larval gut (Mumcuoglu et al. 2001). It has been shown that L. sericata encodes 47 AMP genes, which 
represent the highest amount of AMPs among Diptera (Pöppel et al. 2015). More than 20 of which have 
been synthesized or produced recombinantly and displayed activities against a broad spectrum of 
microbes (Barnes et al. 2010; Pöppel et al. 2014).The antimicrobial activity of maggot secretions has a 
dose-dependent relationship according to the number and nature of bacteria the larvae encounter (Barnes 
et al. 2010; Cazander et al. 2009a) and shows activity against antibiotic resistant pathogens e.g. 
Methicillin-resistant Staphylococcus aureus (MRSA) (Bexfield et al. 2008; Bowling et al. 2007). The 
secretions of sterile larvae do not possess antimicrobial activity whereas larvae confronted with 
Staphylococcus aureus or Pseudomonas aeruginosa (the most prominent Gram-positive and Gram-
negative bacteria in chronic wounds, respectively (Davies et al. 2004; Fazli et al. 2009; Mihai et al. 2014) 
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produce distinct antimicrobial secretions that are not mutually antagonistic (Kawabata et al. 2010). Both 
S. aureus as well as P. aeruginosa are well known to form biofilms, which protect them against various 
external cues and considerably hamper the treatment (McCarthy et al. 2015; Tolker-Nielsen 2014). 
Maggot proteases have been shown to be upregulated upon immune challenge (Altincicek and Vilcinskas 
2009) and responsible for the inhibition or degradation of bacterial biofilm (Brown et al. 2012; Cazander 
et al. 2009b; Harris et al. 2013; van der Plas et al. 2008). 
Wound healing and tissue remodeling (III) is an extremely complex process involving many different 
factors (Broughton et al. 2006). Although it is hard to quantify the direct positive effect of MDT on 
wound healing and tissue remodeling, there are several studies dealing with these benefits (Cazander et 
al. 2013). Various serine proteases have been shown to play multiple roles. They for example do not only 
show procoagulant properties, but cleave extra cellular matrix components (Kahl et al. 2015; Pöppel et 
al. 2016), thus enabling increased fibroblast migration to the wound bed to accelerate the healing process 
(Horobin et al. 2005; Horobin et al. 2006). The amino acid derivatives 3-guanidinopropionic acid, 
L-valinol and L-histidine have been shown to be secreted and stimulate angiogenesis (Bexfield et al. 
2010). Also the suppression of pro-inflammatory responses (van der Plas et al. 2007; van der Plas et al. 
2009) and an increased rate of tissue granulation (Sherman 2002) have been observed for MDT. Low 
molecular compounds, such as allantoin, urea or ammonium bicarbonate are present in E/S and involved 
in maintaining the alkalinity of the wound (Fleischmann et al. 2004). Moreover, allantoin and urea are 
presumed to have healing properties since 1930s (Robinson 1935), which led to their utilization in many 
cosmetic products. Recently, allantoin was shown to accelerate the establishment of normal skin in rats 
using an experimental open wound model (Araujo et al. 2010). 
To deliver the sterile larvae for the treatment of chronic wounds fly eggs are disinfected by rinsing with 
sodium hypochlorite and subsequently reared on sterile culture medium. In Germany BioMonde 
(http://biomonde.com/us/) is the main distributor of medical maggots. They offer both common 
application forms. In the free-range format (Figure 7A) larvae are applied directly to the wound bed and 
kept in place by a sophisticated cage-like dressing. This is especially useful for hard to access areas (e.g. 
body cavities) but could be also associated with increased level of pain, especially in patients that showed 
wound pain even before treatment. In the second format maggots are enclosed in a Biobag, which usually 
consist of polyvinylalcohol mesh (Figure 7B) (Fleischmann et al. 2004). This semipermeable membrane 
keeps the maggot in the right place and allows E/S to reach the wound and liquefy necrotic tissue. 
Predigested tissue can also pass the membrane back and is ingested by larvae. This eliminates the 
discomfort and pain of patients caused by maggots crawling in the wound bed and the risk of maggots 
escaping the wound, but comes at the cost of a slower debridement (Thomas et al. 2002). In both formats 
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the maggots are kept on the wound for 2-4 days with ~8 maggots per cm2. After each treatment cycle the 
healing progress is evaluated and fresh 1st instar maggots are applied until the wound has entered the 
healing phase. A secondary occlusive dressing is always needed to soak up excessive liquid to prevent 
the maggots from drowning. This dressing has to allow oxygen to pass so the maggots do not suffocate. 
The dressing has to be checked and changed regularly (Grassberger et al. 2013). 
 
Figure 7: MDT treatment of chronic wounds. (A) Free-Range larvae, (B) larvae in Biobag. 
 
With more than 80,000 patients treated over the last 20 years (Mumcuoglu et al. 2012), MDT holds an 
immense potential. However, it is still a niche treatment, because the use of living therapeutic animals is 
not well received neither by patients nor medical personal. In addition, short shelf life and the need for 
careful control to avoid the spread of disease (e.g. by mature flies) in hospitals remain a challenge. 
Presently, several groups worldwide have started to characterize and isolate beneficial substances from 
maggots (Fleischmann et al. 2004; Pöppel et al. 2016; Valachova et al. 2014). The aim of these efforts 
is to produce defined molecules with therapeutic value either synthetically or in recombinant form. This 
would provide the base for the development of maggot-derived treatments without applying live 
maggots, expected to be associated with significantly reduce side-effects and improved acceptance by 
the patients. Furthermore, defined maggot-derived compounds could be evaluated for other indications 
besides wound care. 
 
1.4. qRT-PCR and reference genes 
Quantitative reverse transcription polymerase chain reaction (qRT-PCR) is a well established and 
powerful tool for mRNA detection and quantification. It exploits the proportional relationship of input 
target amount to amplified target in the exponential PCR amplification phase. The amount of amplified 
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target is detected by a fluorescent readout at the end of each PCR cycle. The first time this signal reaches 
a set threshold is the so called quantification cycle (Cq). This results in a method that is fast, cheap, 
highly sensitive and good reproducible over a wide dynamic range (Bustin 2002). In consequence many 
parameters have to be carefully controlled to assure the high sensitivity in order to use it as a reliable 
quantification method. Among these are amplification of unspecific products in PCR, mRNA integrity, 
efficiency of cDNA synthesis, differences in overall transcriptional activity and other random variations 
caused by various biological and experiment factors (Bustin et al. 2009; Nolan et al. 2006). Ultimately 
the absolute quantification is only possible by comparison to a standard curve of known target 
concentrations. 
If those standards are not available relative comparison between samples can give useful and relevant 
answers to many biological questions (Nijhof et al. 2009), but a simple comparison of target gene Cq 
values is not able to give any kind of reliable results. Therefore, a comparison to a known reference is 
required (Bustin et al. 2009; Vandesompele et al. 2002). This is usually another gene (reference gene) in 
the same sample. Those reference genes are supposed to be stably expressed and because they share the 
sample history with the target gene they eliminate many systemic errors. This strategy is known as the 
ΔΔCq method displayed in equation (1). Relative change ratio is calculated under consideration of primer 
pair efficiency (E) and ΔCp of target and reference gene in sample A and B (Pfaffl et al. 2002). 
ratio	 ൌ ൫E୲ୟ୰୥ୣ୲൯
∆େ୯౪౗౨ౝ౛౪ ሺୱୟ୫୮୪ୣ	୅	ିୱୟ୫୮୪ୣ	୆ሻ
ሺE୰ୣ୤ሻ	∆େ୯౨౛౜	ሺୱୟ୫୮୪ୣ	୅	ି	ୱୟ୫୮୪ୣ	୆ሻ 		ሺ1ሻ 
An ideal reference is a gene that is stable and equal expressed over all samples under every experimental 
treatment. Such a gene probably does not exist and the comparison to a single gene has been proven to 
be insufficient so comparison to two or more genes is mandatory (Bustin et al. 2009; Gutierrez et al. 
2008). To validate the stable expression of potential reference genes different algorithms like Normfinder 
and GeNorm have been developed that compare different candidates among each other to identify the 
best gene or a set of genes (Andersen et al. 2004; Vandesompele et al. 2002). This has to be done not 
only for every organism, because gene expression differs significantly, it is also necessary for different 
experiment setups like immune challenges or sampling from various tissues. Although reference genes 
are critical to obtain any reliable results they are often overlooked. This is one of the reasons why the 
strict MIQE guidelines (Minimum Information for Publication of Quantitative Real-Time PCR 
Experiments) were introduced (Bustin et al. 2009).  
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1.5. Urate Oxidases, allantoin and purine catabolism 
Urate Oxidase (UO; EC 1.7.3.3) is a key enzyme in purine catabolism that degrades the lowly soluble 
uric acid to allantoin (Figure 8). Allantoin was already observed in maggot treated wounds nearly 100 
years ago and attributed to healing properties (Robinson 1935). Lack of molecular methods and 
biochemical approaches made it impossible to identify the enzyme responsible for allantoin production 
and the underlying mechanism in wound healing could not be deciphered. Nowadays allantoin is 
assumed to cause a local and temporal multiplication of leukocytes during wound healing which hastens 
the healing process (DiSalvo 2002). The name Allantoin comes from allantois, an embryonic excretory 
organ of most mammals, where allantoin accumulates during development. Due to its presumed healing 
properties allantoin is a part of many cosmetically products. 
 
Figure 8: UO reaction mechanism. 
 
The reaction of UOs was well studied during the last 20 years and revealed that the enzyme catalyzes 
the oxidation of uric acid to 5-hydroxyisourate and hydrogen peroxide. 5-hydroxyisourate spontaneously 
decomposes to 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline and subsequently to allantoin and 
carbon dioxide (Fetzner and Steiner 2010). UO is not depend on either a cofactor or a transition metal 
ion, which is uncommon for an oxidase (Gabison et al. 2006). UOs are ubiquitously present in bacteria, 
archaea and eukaryotes (Alvarez-Lario and Macarron-Vicente 2011). In vertebrates, the enzyme is 
present in the liver and frequently also in the kidney. It is located in peroxisomes and forms 
paracrystalline arrays, which are detectable by electron microscopy (Hayashi et al. 2000). Crystal 
structure of UO is so far only available for bacterial and fungal UOs, because they build soluble 
homotetrameric proteins. These form a dimer-dimer structure resulting in a tunneling-fold (T-fold) 
known for many homotetrameric proteins (Colloc'h et al. 1997; Juan et al. 2008). 
Allantoin, the end product of the UO reaction, is not the end product of purine catabolism in most 
organisms. This ubiquitous catabolic pathway end only in mammals (except humans and higher 
primates) with allantoin. In fish and amphibians nitrogenous wash products are degraded down to urea 
and in marine invertebrates to ammonia. In purine catabolism, allantoin gets further degraded by 
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Allantoinase to allantoic acid and by Allantoicase and Urease down to urea and ultimately ammonia as 
the most reduced nitrogen form (Alvarez-Lario and Macarron-Vicente 2011; Fujiwara and Noguchi 
1995) (Figure 9). In insects Urease activity is unusual, because they lack the excess of water to counter 
act the toxic effects of high ammonia amounts (Wright 1995). Allantoicase activity is rare and cannot be 
simply attributed to urea detection, because urea can also be 
produced by other pathways (Scaraffia et al. 2008). Urea is also 
observed in maggot treated wounds and like allantoin attributed 
to healing properties (Sherman 2014). Allantoinases activity was 
assumed to be present only in a few insect species (Bursell 1967; 
Kuzhivelil and Mohamed 1998) by the detection of allantoic acid. 
Due to multiple loss of function mutations during evolution UO 
is an inactive enzyme in humans and higher primates (Keebaugh 
and Thomas 2010). The purine catabolism in humans ends by 
lowly soluble uric acid with direct impact on human health 
(Alvarez-Lario and Macarron-Vicente 2010). At physiological 
pH a uric acid concentration of ≥ 6.8 mg/dL (400 µM) in body 
fluids is described as hyperuricemia. Which is ten times less 
soluble compared to allantoin. The evolutionary advantage of 
high uric acid concentrations for early primates is still unclear. 
One prominent theory attributes it to the high antioxidant capacity 
of uric acid, which is responsible for the neutralization of > 50 % 
of free radicals in human blood (Alvarez-Lario and Macarron-
Vicente 2011). 
Precipitation of uric acid leads to gout, kidney stones, tumor lysis 
syndrome (TLS) and other medical complications (Alvarez-Lario 
and Macarron-Vicente 2011; Del Toro et al. 2005; Kim et al. 
2016). In TLS high levels of uric acid occur by simultaneous lysis 
of tumor cells during chemotherapy. Those precipitate in the 
kidney, lead to acute renal failure and ultimately the death of 
patients (Davidson et al. 2004). To prevent those severe side 
effects the reduction of plasma uric acid levels weeks before 
chemotherapy is often necessary. Rasburicase is an FDA  
approved UO for prevention of TLS in chemotherapy (Mayne et Figure 9: General purine catabolism
pathway overview. 
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al. 2008). It originates form the fungus Aspergillus flavus and is recombinantly produced in the yeast 
Saccharomyces cerevisiae to reduce immunogenicity. Nevertheless it is not suitable for gout or kidney 
stones which would require long term UO application (Bomalaski et al. 2002; Goldman et al. 2001). To 
avoid long term uric acid precipitations allopurinol is currently the standard treatment. It is a competitive 
inhibitor of xanthine oxidase and thus inhibits the production of uric acid (Burns and Wortmann 2011). 
Long term application of allopurinol leads to accustoming in some patients. Due to its low solubility, 
similar to that of uric acid, this effect is not compensated by an increase in allopurinol dosage and uric 
acid is not reduced to the desired level anymore. Those cases are known as treatment failure gout and 
create an urgent need for an alternative solution UO can offer (Edwards 2008).
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2. Aim of the project 
Maggot debridement therapy (MDT) has been shown to promote wound debridement, disinfection and 
hastened healing processes, hence molecules present in larval E/S represent a rich source of new 
therapeutics (Sherman 2014). In this complex mixture of enzymes, AMPs and small molecules it is hard 
to decipher the roles and benefits of individual components in the wound healing process (Davydov 
2011). The falling cost of next generation sequencing promote the sequencing of genome and 
transcriptome datasets even from non-model organisms. Those can be used as a first step to screen for 
medically and industrially relevant protein sequences. In a second step qRT-PCR can validate these 
candidates, but only if appropriate reference genes are available for the normalization of expression data 
(Gutierrez et al. 2008; Pfaffl et al. 2002; Vandesompele et al. 2002). This approach is ideal for the 
identification of L. sericata genes with important roles in wound healing. Thus such genes are likely to 
show different expression profiles in specific tissues or are modulated in the presence of wound 
pathogens. Once the candidate genes are identified the next challenge is to provide them in sufficient 
amount and purity for detailed analysis. One of the possibilities is heterologous production of 
recombinant proteins. In the last years the first L. sericata enzymes, two serine protease that support 
debridement and degrade extracellular matrix components (Pöppel et al. 2016; Telford et al. 2010) and 
three lysozymes contributing to disinfection (Valachova et al. 2014), were produced recombinantly. 
These enzymes were tested for their application potential and broadened our understanding of MDT 
mediated wound healing. 
The observation that allantoin is present in maggot treated wounds was already made in 1935 (Robinson 
1935). Since this time, allantoin is a part of many cosmetics products (DiSalvo 2002) and recently its 
accelerated establishment of normal skin was quantified in rats using an experimental open wound model 
(Araujo et al. 2010). The aim of this thesis was to validate reference gene candidates to enable tissue 
specific gene expression analysis via qRT-PCR and further to produce, characterize and understand the 
role of the allantoin producing enzyme(s) of L. sericata and its role in MDT. 
Based on this state of knowledge the following topics were set as the main objectives of this thesis: 
Validation of reliable L. sericata reference genes for candidate profiling 
- For tissue specific profiling focused on secretory tissues 
- For differential expression after immune challenge with Gram-negative bacteria 
Identification and characterization of candidate enzyme(s) for allantoin production 
- Localization in maggot tissues and role in wound healing 
- Recombinant production and assessment of enzymatic properties 
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3. Methods 
All standard molecular biology methods and biochemical approaches were performed based on 
Gentechnische Methoden 5th edition (Jansohn and Rothhämel 2012) or Molecular Cloning: A Laboratory 
Manual Methoden 4th edition  (Green and MacCallum 2012) if not stated otherwise. For a short overview 
see Baumann et al. (2015) and Baumann et al. (2016) (submitted to Insect Biochemistry and Molecular 
Biology). For detailed information on all chemicals and material used in this study see supplement A. 
 
3.1. Lucilia sericata 
3.1.1. Maggot rearing 
L. sericata larvae were obtained from BioMonde GmbH and transferred to Bioreactor 50 vented culture 
tubes (TubeSpin) using entomological forceps made of spring steel. First instar larvae were reared on 
Columbia Agar with Sheep Blood PLUS (Thermo Scientific Oxoid) for 72 hours (h) at 28 °C in the dark. 
The 3rd instar larvae were cleaned using sterile water before immune challenge or dissection. 
3.1.2. Immune challenge and zone of inhibition assays 
Larvae were placed in Petri dishes on ice to reduce motility and facilitate injection of larvae with 
Pseudomonas aeruginosa. The dorsal posterior was pricked with a sterile 0.5 x 16 mm needle (wounded) 
or with a needle dipped in P. aeruginosa (DSM 50071) suspension (OD600 = 60) in PBS (immune-
challenged). Treated larvae were supplied with fresh blood agar and incubated for additional 24 h at 
28 °C in the dark followed by the dissection of individual tissues. For the zone of inhibition assays, 7 ml 
of 1 % LB agar per plate was cooled to 42 °C, supplemented with 7 μl of fresh E. coli D31 (Monner et 
al. 1971) culture (OD600 = 0.5) and poured into a Petri dish, before 3-mm wells were stamped into the 
agar using a sterile hole puncher. After 24 h equal volumes (3 μl) of hemolymph from naïve, wounded 
and immune-challenged larvae were collected and immediately applied to the agar wells. The plates were 
incubated at 37 °C for 24 h and 3 μl of 100 mg/ml ampicillin were used as a positive control. 
3.1.3. Tissue dissection 
Larvae were cooled on ice and dissected using fine tip tweezers (Type 5, Dumont) by ripping the dorso-
anterior cuticle in sterile 0.1 % DEPC treated PBS under a binocular microscope. The midgut, hindgut, 
salivary glands, crop, fat body, Malpighian tubes and nerve ganglion were harvested following Freeman 
and Bracegirdle (1971). Tissues were dissected in RA1 buffer (Macherey-Nagel) for RNA isolation (see 
3.2.1) or in 1 x Laemmli-buffer for protein isolation (see 3.4.2). 
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3.2. RNA based L. sericata studies 
3.2.1. RNA isolation 
Total RNA from naïve and immune-challenged larvae as well as tissues, was extracted using the 
NucleoSpin RNA kit (Macherey-Nagel) according to manufacturer’s recommendations. Those included 
a 15-min DNase I on-column digest and RNA was ultimately eluted in 60 µl (larvae) or 40 µl (tissues) 
RNAse free H2O, respectively. Three pools of midgut (n = 5), hindgut (n = 10), salivary glands, crop, fat 
body, Malpighian tubes and nerve ganglion, (each n = 25) were collected in RA1 buffer, before RNA 
isolation. Total RNA from naïve and immune-challenged larvae (n = 5) was subsequently pooled in 
equimolar RNA amounts. Concentration and purity of RNA were determined by spectrophotometry 
(Take3, BioTek). Only samples with A260/A280 and A260/A230 > 1.8 were further tested for quality by 
agarose gel electrophoresis. Samples that did not meet these criteria were cleaned and concentrated by 
sodium acetate precipitation (see 3.2.2). 
3.2.2. RNA purification by sodium acetate precipitation 
To clean and concentrate isolated RNA, which was not already suitably for cDNA synthesis sodium 
acetate precipitation based on Walker and Lorsch (2013) was applied. RNA was supplemented with 3 M 
RNAse free sodium acetate (pH 5.2, Thermo Fisher Scientific) to a final concentration of 0.3 M. 3 
volumes of ice cold p. a. ethanol (100 %) were added, mixed and RNA precipitated at -20 °C overnight. 
Samples were centrifuged (18000 g, 30 min, 4 °C), washed (2 x) with 500 µl ice cold ethanol (80 %) and 
centrifuged (18000 g, 10 min, 4 °C). After the second wash the solution was removed and the pellet 
allowed to air dry. The pellet was resuspended in RNAse free H2O and resulting RNA concentration and 
purity were determined spectrophotometrically (Take3, BioTek) like in 3.2.1. 
3.2.3. RNA quality control by agarose gel electrophoresis 
Since photometric analysis are unable to indicate RNA degradations the RNA quality was determined 
by agarose gel electrophoresis. 1 µg total RNA was supplemented with 5 x RNA loading buffer (8 M 
urea, 0.5 mM EDTA, 0.1 % Bromphenol blue, 0.1 % Xylene cyanol) and filled with ddH2O to 10 µl. 
Samples were not heated to avoid degradation and transferred to a 1.2 % agarose gel with fresh TAE 
buffer. RNA was size separated for 45 min at 100V and samples were post stained with SYBR Safe 
(0.005 % in TAE) for 10 min. Followed by visualization using a Versadoc Imaging System (Bio-Rad). 
Only samples with at least one sharp band representing 18S rRNA were used for cDNA synthesis. 
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3.2.4. cDNA synthesis 
Complementary DNA (cDNA) was synthesized using 1.5 μg of total RNA, oligo(dT)18 primers and the 
First Strand cDNA Synthesis Kit (Thermo Fisher Scientific) according to manufacturer’s 
recommendations. The resulting cDNA was diluted to a working concentration of 400 pg/μl, divided into 
aliquots and stored at –80 °C. 
3.2.5. Candidate gene sequence assembly 
The 10 L. sericata reference gene candidates were selected based on known reference genes from the 
closely-related species Lucilia cuprina (Bagnall and Kotze 2010) and other arthropods (Beckert et al. 
2015; Nijhof et al. 2009). Urate oxidase and further purine catabolism gene candidates (allantoinase, 
allantoicase and urease) were searched based on sequences from insects (Scaraffia et al. 2008) and other 
organism (Fujiwara and Noguchi 1995). The peptide sequences of each gene (or the nucleotide sequences 
of 18S and 28S rRNA) were queried against the L. sericata transcriptome database (Pöppel et al. 2015) 
using the BLAST algorithm. BLASTn was used to find all reads matching the search results and the pool 
of these reads was expanded to include further paired-end read partners. The final group of reads was 
assembled using Trinity (Grabherr et al. 2011) and this step was repeated until the complete coding 
sequences were acquired. Finally, Gap5 (Bonfield and Whitwham 2010) was used to verify the finished 
sequences with mapped reads assembled by Bowtie (Langmead et al. 2009). Whole coding sequences of 
all assembled genes were submitted to GenBank (Table 1). 
Table 1: Genes and qRT-PCR primers evaluated in this thesis. 
Gene name Abbreviation Accession no. Primer sequences (5'-3') L (bp)a  E (%)b R2c 
18S ribosomal RNA 18S rRNA KR133393* Fwd 5' AGCAGTTTGGGGGCATTAG 3' 171 94 0.996 
   Rev 5' GCTGGCATCGTTTATGGTTAG 3'    
28S ribosomal RNA 28S rRNA KR133394* Fwd 5' CCAAAGAGTCGTGTTGCTTG 3' 180 91 0.997 
   Rev 5' ATTCAGGTTCATCGGGCTTA 3'    
40S ribosomal protein S3 RPS3 KR133395* Fwd 5' TCAAGGTGTTTTGGGTATCAAGG 3' 156 90 0.999 
   Rev 5' GCGGGCATTTTGTATTCTGTTTC 3'    
60S acidic ribosomal protein P0 RPLP0 KR133397* Fwd 5' GGTGCTGATAATGTTGGTTC 3' 78 101 0.995 
   Rev 5' ACCCATAAGGACGACACC 3'    
actin actin KR133398* Fwd 5' TGCCGATCGTATGCAAAA 3' 90 100 0.998 
   Rev 5' ACGGAGTATTTGCGTTCTGG 3'    
allantoinase Alla KX840072* Fwd 5'ATCGGAGGCGGTATATGACTTTG 3' 116 95 0.991 
   Rev 5' TTGTGGCGGTTAAAAATCCTTC '3    
attacin-2 atta2 KR920003* Fwd 5' GCACCTTAGCCTACAATAACAATGG 3' 92 103 0.999 
   Rev 5' ACTGATGCTCTTGGTCAAAGTATCG 3'    
Beta-1-tubulin ß-tubulin KR133399* Fwd 5' AAACTAACCACACCCACATACGG 3' 173 90 0.999 
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Gene name Abbreviation Accession no. Primer sequences (5'-3') L (bp)a  E (%)b R2c 
   Rev 5' AGAGGAGCAAAACCAGGCAT 3'    
cAMP-dependent protein kinase  PKA KR133400* Fwd 5' CAACACAAGCCGACAAAAGAC 3' 145 106 0.995 
   Rev 5' GATAGCGTAGGGAAACCAAGAA 3'    
defensin-1 def1 KT149727* Fwd 5' CGGAGTTACATGGTCGTTACAAGAG 
3' 
164 109 0.993 
   Rev 5' CGGTGTCCAATCAACAAACAGTG 3'    
Elongation factor 1-alpha 1 EF1α KR133396* Fwd 5' TGTCGGTGTCAACAAGATGG 3' 137 93 0.998 
   Rev 5' GAGATGGGAACGAAGGCAAC 3'    
Glutathione S-transferases 1-1 GST1 KR133402* Fwd 5' GCCAGTGTCAGCACCTTCG 3' 120 92 0.999 
   Rev 5' GCAACCTTCCCAGTTTTCATC 3'    
Glyceraldehyde-3-phosphate dehydrogenase 1 GAPDH KR133401* Fwd 5' GAACGGCAAACTCACTGGTATG 3' 182 104 0.997 
   Rev 5' CGGTGGAAACGACTTCTTCATC 3'    
lucimycin afp KJ413251 Fwd 5' TCGCTTTAATCGCCGTTGTT 3' 103 96 0.999 
  Rev 5' ATGATGCCCAGCCTGTTGTTC 3'    
urate oxidase  UO KX840071* Fwd 5' ACCCAAACAAACCGTTATTAGCG '3 150 96 0.996 
   Rev 5' TCCCAAGAACAATCAACAATCG 3'    
*Indicates GenBank submission of sequence obtained in this thesis. 
aLength of amplicon. bQuantitative RT-PCR efficiency. cCoefficient of determination. 
3.2.6. Primer design and evaluation for qRT-PCR 
Gene-specific primers were designed using Oligo Explorer v1.1.2 (http://www.softpedia.com/ 
get/Science-CAD/Oligo-Explorer.shtml) to yield primers 19–23 nucleotides in length with amplification 
products of 50–210 bp and Tm values of ~60 °C. All primers (Table 1) were ordered from Sigma-Aldrich 
and subsequently tested in a standard curve assay including melt curve analysis using the StepOnePlus 
Real-Time PCR System (Applied Biosystems). The cDNA concentrations corresponding to 50-3.2 ng of 
total RNA were used in 5-fold dilutions with the cycling conditions recommended by the manufacturer. 
Briefly, hot-start PCR with denaturation at 95 °C for 10 min was followed by 40 cycles of 95 °C for 15 
s and 60 °C for 60 s, and finally the melt curve analysis with a temperature increase from 60 °C to 95 °C 
in 0.5 °C steps. Reaction efficiency was calculated using StepOne Software v2.3 and only primers with 
an efficiency of 90–110 %, R2 ≥ 0.99 and a single sharp melt curve peak were used for further analysis. 
3.2.7. Quantitative RT-PCR 
Quantitative RT-PCR was carried out on a StepOnePlus system (Applied Biosystems) using optical 96-
well plates (Applied Biosystems). The total reaction volume of 10 μl contained 5 μl Power SYBR Green 
PCR Master Mix (Applied Biosystems), 1 μl (400 pg; 10 ng in case of allantoinase) cDNA and 300 nM 
of each primer pair except for β-tubulin (150 nM), EF1α (150 nM) and actin (450 nM forward primer 
and 150 nM reverse primer). All reactions were carried out in three technical replicates under the reaction 
conditions stated above (see 3.2.6). Baseline correction was performed automatically by StepOne 
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Software v2.3 and the quantification cycle (Cq) was always determined at an intensity of 0.15. All cDNA 
samples and corresponding RNA without reverse transcription (no-RT control) were tested with the 18S 
rRNA primers to estimate the remnants of genomic DNA (Bustin 2002) and only samples with a ΔCq ≥ 
10 were accepted. 
3.2.8. Normfinder and GeNorm analysis 
The Normfinder and GeNorm algorithms were used to assess all L. sericata reference genes. Normfinder 
was used as an add-in for Microsoft Excel (http://moma.dk/normfinder-software), raw Cq values were 
used and log transfer was performed by the software. The model-based Normfinder approach relies on 
groups of sample types (tissues in this case) and should be used with 5-10 candidate reference genes. It 
estimates intragroup and intergroup variation of every single reference gene separately and subsequently 
combines them into a so-called stability value. Lower numbers equating a more stable expression. The 
program does not sequentially eliminate unsuitable genes so the pre-exclusion of genes with large 
variances is necessary to achieve reliable results (Andersen et al. 2004). 
GeNorm was used as part of the R package NormqPCR with R version 3.1.1 (Perkins et al. 2012). Raw 
Cq values were used and log transfer was performed by the software. The GeNorm algorithm is based 
on the principle that the expression ratio of two ideal control genes is identical throughout all samples. 
In consequence any variation implies that these genes are not equally expressed whereas the bigger this 
difference the lower the expression stability. By calculating the standard deviation of expression ratios 
for every control gene with all other candidates the algorithm determines gene variation. The gene-
stability measure M is the average of this pairwise variation and genes with the lowest M value are most 
stable. The gene with the highest M value gets excluded and another comparison cycle is calculated until 
only the best two genes are left. By excluding the least suited candidate in every cycle no exclusion of 
unsuited genes prior to analysis is needed (Vandesompele et al. 2002). 
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3.2.9. Gene expressions analysis 
To evaluate the tested reference genes three L. sericata immune genes (lucimycin, defensin-1 and 
attacin-2) were selected. Those are known to be differentially expressed, when the larval immune system 
was challenged (Pöppel et al. 2015). The AMPs were chosen based on their activity spectrum, with 
lucimycin (afp) targeting fungi (Pöppel et al. 2014), defensin-1 targeting Gram-positive (Imler and Bulet 
2005) and attacin-2 targeting Gram-negative bacteria (Imler and Bulet 2005), respectively. Gene 
expression profiles upon immune challenge were determined by qRT-PCR using the ΔΔCq method 
(Pfaffl 2001) in Rest2009 (http://www.genequantification.de/rest-2009.html). Efficiencies greater than 
100 % were set to 100 % because Rest2009 does not allow higher values. The data were normalized 
using three different combinations of genes from the reference gene assessment: (a) the two best 
reference genes for every sample (GeNorm); (b) the three overall best reference genes (GeNorm and 
Normfinder); and (c) the six overall best reference genes (GeNorm). 
The three overall best reference genes provided by both GeNorm and Normfinder (RPS3, RPLPO and 
EF1α) were used for further analysis. To determine gene expression profiles among naïve tissues relative 
ΔΔCq compassion like above was applied. Expression was compared to the tissue with the lowest 
expression, which was nerve ganglion for urate oxidase and fat body for allantoinase. 
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3.2.10. RNA in situ hybridization (ISH) 
In situ hybridization assay was modified from (Valachova et al. 2014; Zimmerman et al. 2013). 
Malpighian tubes were dissected directly into 4 % paraformaldehyde (in PBS) and fixed overnight at 
4 °C. Samples were washed (3 x 10 min) in PBS containing 0.2 % Tween 20 (PBST) and treated by 
Proteinase K (50 µg/ml in PBST) for 10 min at room temperature. Samples were incubated 5 min at 
room temperature in PBST-Glycin (2 mg/ml), washed (2 x 5 min) in PBST, refixed in 4 % 
paraformaldehyde (in PBS) for 1 hour at room temperature and washed again (1 x 5 min) in PBST. Next, 
the samples were equilibrated in 1:1 PBS:hybridization solution (HS: 50 % formamide, 5 x saline-sodium 
citrate, 50 µg/ml Heparin, 100 µg/ml Salmon testes DNA, 0.1 % Tween 20, all components from Sigma-
Aldrich, Munich, Germany) for 5 min and in HS for 5 min at room temperature followed by incubation 
in HS for 1 hour at 48 °C. UO and RPS3 (positive control) specific primers (Table 2) were used to 
synthetize gene specific probes using PCR DIG Probe synthesis kit (Roche, Mannheim, Germany) 
according to manufacturer´s instruction. Probes (10 µl) were mixed with 90 µl of HS solution, boiled for 
45 min in a water bath and incubated with samples for 24 h at 48 °C. The probes were then removed and 
tissues were washed in pre-warmed (48 °C) HS overnight. Next, the samples were washed (1 x 5 min) 
with pre-warmed (48 °C) HS, HS:PBST (1:1) and (2 x 10 min) PBST followed by blocking with 1 % 
BSA in PBST for 30 min at room temperature. The blocking agent was removed and samples were 
incubated overnight at 4 °C with the alkaline phosphatase (AP)-labelled sheep anti-digoxigenin antibody 
(1:1000 in PBST; Roche, Mannheim, Germany). Samples were washed (3 x 5 min) with AP buffer 
(100 mM Tris pH 9.5, 50 mM MgCl2, 100 mM NaCl, 0.1 % Tween-20) and stained with nitroblue 
tetrazolium and bromo-chloro-indolyl-phosphate solution (NBT-BCIP, Roche, Mannheim, Germany) 
diluted 1:50 in AP buffer. The color development of the UO probe was controlled under the binocular 
microscope, stopped by PBS washes (3 x 5 min) and the same time applied for the control probes. 
Unspecific staining was removed by wash (2 x 10 min) with 70 % Ethanol (in PBS), (2 x 5 min) 100 % 
ethanol and samples were mounted on glass slides in 90 % glycerol. HS solution and nonspecific probe 
(PCR DIG Probe synthesis kit) were used as negative controls. Results were analyses using a Mz16 F 
microscope (Leica Microsystems). 
Table 2: ISH primer used in this thesis. 
Gene name Abbreviation Accession no. Primer sequences (5'-3') 
40S ribosomal protein S3 RPS3 KR133395 Fwd 5' GGGTTGCGAAGTCGTTGTTT 3' 
   Rev 5' GCGGGCATTTTGTATTCTGTTTC 3' 
Urate oxidase  UO KX840071* Fwd 5' CTCCCAACTTTTCCACATTCAA 3' 
   Rev 5' TCCCAAGAACAATCAACAATCG 3' 
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3.3. Production and characterization of recombinant Urate Oxidase (UOr) 
3.3.1. UOr sequence synthesis 
To produce the L. sericata UO recombinant (UOr) in E. coli a synthetic codon-optimized gene encoding 
the deduced amino acid sequence was synthesized by Eurofins MWG Operon (Ebersberg, Germany) and 
subcloned into the E. coli expression plasmid pASK IBA37plus (IBA) containing an N-terminal His6-
Tag (Figure 10). 
 
Figure 10: DNA and protein sequence of codon optimized L. sericata Urate Oxidase. Including N-terminal His6-
Tag (black box) and Factor Xa motive (grey box). 
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3.3.2. Production of UOr in E. coli  
Chemical competent E. coli BL21(DE3) cells (New England Biolabs) were transformed with the UOr 
expression plasmid (25 ng) in according to manufacturer’s recommendations. Cells were grown in 
terrific broth medium (Roth) to an OD600 of 0.9 before the expression was induced by 200 µg/l 
anhydrotetracyline and carried out for 3 h at 37 °C and 180 rpm. Followed by harvest (5000 g, 10 min, 
10 °C), resuspendation in lysis buffer (30 mM Tris, 100 mM NaCl, pH 7.5) and lysis using a MP110PS 
high pressure microfluidiser (Microfluidics, Newton, US). Lysed cells were centrifuged (75000 g, 
30 min, 10 °C) and pelleted inclusion bodies were solubilized in chaotropic buffer (8 M guanidine 
hydrochloride, 30 mM Tris, pH 7.5) by stirring overnight at room temperature. The remaining insoluble 
fraction was removed by additional centrifugation (75000 g, 30 min, 10 °C) prior purification. 
3.3.3. IMAC purification of UOr 
UOr was purified by cobalt-based IMAC under denaturing conditions using a SE-04 FPLC system 
(ECOM) fitted with a column containing TALON resin (Clontech). The lysate was loaded onto the 
column and washed with buffer A (6 M urea, 30 mM Tris, 100 mM NaCl, pH 7.5). Recombinant enzyme 
was eluted by buffer B (6 M urea, 30 mM Tris, 100 mM NaCl, 200 mM imidazole, pH 7.5) and fractions 
containing UOr were collected manually by absorption at 280 nm and analyzed by SDS-PAGE. 
3.3.4. SDS-PAGE 
Size separation of proteins by denaturing SDS-PAGE was performed with a 4–15 % Mini-PROTEAN 
TGX Gel (Bio-Rad) in a Mini-PROTEAN Tetra System (Bio-Rad). Samples were supplemented with 
3 x Laemmli-buffer containing 2 % β-mercaptoethanol (Fc) and denatured for 10 min at 95 °C. Samples 
and a protein size standard (PageRuler Plus, Fermentas) were loaded on the gel and separated at constant 
voltage (300 V) for 18 min. Gels were used for Western Blot (3.4.2) or stained with Roti-blue quick 
(Roth) coomassie according to manufacturer’s recommendations. Protein bands were documented using 
a Versadoc Imaging System (Bio-Rad). 
3.3.5. UOr refolding by dialysis 
Purified UOr was diluted to a final concentration of 100 µg/ml in elution buffer B (6 M urea, 30 mM 
Tris, 100 mM NaCl, 200 mM imidazole, pH 7.5), supplemented with 1 % β-mercaptoethanol and reduced 
at 37 °C for 20 min. UOr was dialyzed against dialysis buffer (150mM NaCl, 20mM Tris, pH 7.5) for 
18 h at 4 °C and centrifuged (18000 g, 4 °C, 30 min) to remove all precipitated protein. Resulting 
supernatant was dialyzed once more under identical conditions to decrease β-mercaptoethanol 
concentration, centrifuged (18000 g, 4 °C, 30 min). Final protein concentration was determined using 
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the BCA Protein Assay Kit (Pierce; Thermo Scientific) according to manufacturer’s recommendations 
and enzyme was stored at 4 °C for subsequent analysis. 
3.3.6. Determination of UOr pH optimum 
A two-step colorimetric assay (Fraisse et al. 2002) was applied to determine pH optimum of UOr. Briefly, 
in the first reaction step 0.5 mM uric acid in 20 mM corresponding buffer (sodium citrate pH 4-5.5, 
sodium phosphate pH 6-8 or sodium borate 8.5-10) were used (10 min at 25°C). Resulting in allantoin 
and H2O2 production in equimolar amount by UO. The amount of produced H2O2 was monitored in the 
second step by addition of quantification buffer (0.5 mM 3,5-dichloro-2-hydroxybenzene sulfonic acid 
(DCHBS), 0.125 mM 4-amino-antipyrine (4-AAP), 12.5 U/ml horseradish peroxidase (HRP), 0.25 M 
sodium phosphate, pH 6). In this step a stable red quinoeimine dye is formed over a radical-substitution 
reaction induced by H2O2 (Figure 11). The absorbance of the final product was measured at 515 nm after 
10 min at 25°C on an Eon microplate spectrophotometer (BioTek Instruments). 
 
Figure 11: Two-step colorimetric UO assay. (A) Incubation of uric acid with UO results in allantoin, CO2 and H2O2, 
(B) HRP catalysis the DCHBS oxidation  in the presence of H2O2, and (C) The final red quinoeimine dye is 
produced by phenoxyl radical reaction with 4-AAP (according to Fraisse et al. 2002). 
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3.3.7. Determination of UOr temperature optimum, competitive inhibition, metal ion dependence 
and stability 
In all other cases UOr activity was monitored by a continuous assay using Amplex Red Uricase Assay 
Kit (Fisher Scientific). 200 ng enzyme were applied and assay conditions were modified based on 
manufacturer’s recommendations. The stable end product Resorufin was measured at 560 nm after 30 
min using an Eon microplate spectrophotometer (BioTek). 
Temperature optimum was determined in a range of 20-60 °C in 5 °C steps with 0.5 mM uric acid, 50 
µM Amplex Red, 0.2 U/ml horseradish peroxidase and 100 mM sodium chloride in 45 mM Tris-HCl at 
pH 7.5. Competitive inhibition by 8-azaxanthine was tested in a range of 1-1000 µM versus 0.1 mM uric 
acid with 50 µM Amplex Red, 0.2 U/ml horseradish peroxidase and 100 mM sodium chloride in 45 mM 
Tris-HCl, pH 7.5 at 25 °C. Metal ion dependence was tested with 10 mM of corresponding ions (CaCl2, 
MgCl2, MnCl2 ZnCl2 or NiSO4) or 50 mM EDTA in 0.5 mM uric acid, 50 µM Amplex Red, 0.2 U/ml 
horseradish peroxidase and 100 mM sodium chloride in 45 mM Tris-HCl, pH 7.5 at 25 °C. Storage 
stability in assay buffer (100 mM sodium chloride, 45 mM Tris-HCl, pH 7.5) at 25 °C was determined 
after 0, 4, 24 and 168 h. with 0.5mM uric acid, 50 µM Amplex Red and 0.2 U/ml horseradish peroxidase 
at 25 °C. 
3.4. Localization of native UO in larval tissue 
3.4.1. Production of polyclonal anti-UO antibodies 
Antisera containing specific UO polyclonal antibodies against refolded UOr were raised in guinea pig at 
Eurogentec (Seraing, Belgium). Animals were immunized on days 0, 14, 28 and 56 with 60 µg UOr and 
blood was collected on day 87. 
3.4.2. Western blot 
For western blot analysis larval tissues were dissected (see 3.1.3) directly into 1 x Laemmli-buffer and 
homogenize with a metal pestle. Samples were incubated at 95 °C for 10 min and unsoluble material was 
removed by centrifugation (18000 g, 5 min). The supernatant was divided into work aliquots and stored 
at –80 °C. Maggot secretions and excretions (E/S) from 100 maggots (3 days old) were collected in 1 ml 
of PBS for 1 h at 28 °C. Collected samples were supplemented with 3 x Laemmli-buffer and incubated 
at 95 °C for 10 min and work aliquots were stored at - 80 °C. Tissue samples as well as E/S were resolved 
by reducing SDS-PAGE (see 3.3.4) and stained with Roti-Blue quick (Roth) or transferred to a PVDF 
membrane (Merck Millipore) using the TransBlot Turbo Transfer System (Bio-Rad). Membrane was 
blocked for 2 h in Qiagen Blocking Reagent, washed with Tris-buffer saline (TBS) and TBS containing 
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0.1 % Tween 20 (TBST) (3 x 10 min) and incubated at room temperature with polyclonal UO antibodies 
(1:500 in blocking reagent) overnight. After washing with TBS/TBST (3 x 10 min) the membrane was 
incubated with secondary goat anti guinea pig F(ab')2 fragment horseradish peroxidase (HRP) conjugate 
antibody (Dianova) (1:5000 in TBS) for 2 h at room temperature. Readout was facilitated with Lumi-
LightPLUS Western Blotting Substrate (Roche) and the resulting signal was visualized using a Versadoc 
Imaging System (Bio-Rad). 
3.4.3. Whole mount fluorescence immunohistochemistry 
Whole mount staining was modified based on a Harmonia axyridis procedure by Beckert et al. (2016). 
Dissected Malpighian tubes including gut parts were fixed in 4 % formaldehyde in PBS for 45 min. The 
samples were then washed with PBS (3 x 20 min), permeabilized with 0.5 % Triton X-100 in PBS for 1 
h and blocked with blocking solution (Roti-ImmunoBlock, Roth) for 1 h. This was followed by 
incubation with anti-UO antibodies (1:1200 in blocking solution) overnight at 4 °C. Subsequently, 
samples were washed with PBS (3 x 20 min) and incubated with secondary goat anti guinea pig F(ab')2 
fragment Alexa488 conjugate antibody (Dianova) (1:500 in blocking solution) for 2h in the dark. 
Samples were washed with PBS (3 x 20 min), stained with 4, 6-Diamidino-2-phenylindole (DAPI) 
(1 µg/ml) in PBS for 10 min, washed with PBS (3 x 20 min) and mounted in Aqua-Poly/Mount 
(Polysciences) before transferred to a microscope slide. Readout was performed on a Leica Mz16 F 
microscope or a Leica TCS SP8 confocal microscope (Leica Microsystems). 
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4. Results 
4.1. L. sericata reference gene assessment 
Results presented in this section were published under Baumann et al. (2015). 
4.1.1. Candidate genes selection 
To establish normalization of gene expression in various L. sericata tissues I picked 10 candidate 
reference genes and monitored the expression level of those before and after challenging the larvae with 
P. aeruginosa. The goal was to identify reference genes appropriate for different larval tissues, with the 
key criterion that gene expression is not affected by immune challenge. The tissues were selected based 
on their role in secretion and/or digestion (salivary glands, crop, midgut and hindgut) and supplemented 
by additional tissues (nerve ganglion and fat body). Candidates were chosen based on earlier studies in 
arthropods using orthologs of these genes (Bagnall and Kotze 2010; Nijhof et al. 2009). To minimize the 
risk of co-regulation, selected genes representing different functional classes of proteins. The L  sericata 
transcriptome database was explored to identify orthologs and the coding sequences of the 10 selected 
candidate reference genes were submitted to GenBank (Table 1). 
To evaluate the tested reference genes three L. sericata immune genes (lucimycin, defensin-1 and 
attacin-2), which are differentially expressed during immune challenge were selected (Pöppel et al. 
2015). 
Ultimately to identify enzyme candidates for allantoin production our L. sericata transcriptome was 
explored for UO homologs and the search was expanded for further purine catabolism enzymes to 
account for urea production. A single urate oxidase (KX840071) and a single allantoinase gene 
(KX840071) were found and both sequences were deposited to GenBank. Homologues of L. sericata 
allantoicase or urease could not be detected on mRNA level. Without a complete set of enzymes to 
generate urea I focused on the production and subsequent characterization of L sericata UO for uric acid 
degradation and allantoin production. 
4.1.2. Tissue specific RNA quality 
Spectrophotometric measurements of isolated RNA showed values of A260/A280 and A260/A230 > 1.8 for 
all except one crop and three fat body samples in immune-challenged larvae. Those 4 were sodium 
acetate precipitated after the RNA isolation. Spectrophotometric measurements only give information 
regarding RNA purity, but not about overall quality and degradation. As a final quality check agarose 
gel electrophorese was performed to visualize quality of 28S and 18S rRNA to give a hint about the 
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underlying mRNA population. All naïve and immune-challenged samples show at least one sharp band 
representing 18S rRNA (Figure 12) and were suitable for cDNA synthesis. The upper 28S rRNA band 
is visible in most samples, but never exceeds the 18S rRNA band and does not reach the ideal 2:1 ratio 
of a no degraded sample. Malpighian tube collection was not part of the immune-challenge experiment 
and only naïve samples were collected. 
 
Figure 12: L. sericata RNA from naïve (top) and immune-challenged (bottom) larvae and tissues was analyzed 
using agarose gel. One crop and three fat body samples in immune-challenged larvae were sodium acetate 
precipitated after the RNA isolation. Thus they were limited in sample amount they are not displayed in purity used 
for cDNA synthesis. Malpighian tube collection was not part of the immune-challenge experiment and only naïve 
samples were collected. 
 
4.1.3. Quantitative RT-PCR 
The efficiencies of each qRT-PCR primer pair were generally high. Based on the standard curve slopes 
determined using StepOne software, the efficiencies ranged from 90 % to 109 % with R2 values > 0.99 
for all pairs (Table 1). Linear behavior was observed over a concentration range spanning four orders of 
magnitude (50 ng to 3.2 pg of cDNA). The absence of primer dimers was confirmed by a melting curve 
analysis, which resulted in only one sharp peak for each amplicon under those experimental conditions 
(Figure 24 in Sup B.1). All 10 reference genes were expressed in all naïve and immune-challenged 
samples. Median expression values ranged from 19 Cq (18S rRNA) to 26 Cq (PKA) and standard 
deviations ranged from 0.75 Cq (RPS3) to 2.1 Cq (actin) as shown in Figure 13. 
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Figure 13: Distribution of quantification cycle (Cq) values for L. sericata candidate genes obtained by qRT-PCR. 
Data for all naïve and immune-challenged samples were pooled (n = 42). Boxplots show first to third quartile of 
values in the box, the center line indicates the median, vertical dotted bars extend to the highest and lowest value. 
4.1.4. Zone of inhibition assays and initial analysis of attacin-2 expression 
To monitor the changes in larval reference gene expression triggered by interaction with bacteria, I chose 
the opportunistic pathogen P. aeruginosa and direct infection by pricking the L. sericata larvae with a 
bacteria-coated needle (Mulcahy et al. 2014). P. aeruginosa has previously been used to induce an 
immune response (Pöppel et al. 2015) and is also a common pathogen found in chronic wounds. Two 
independent tests were used to monitor the success of the immune challenge.  
The first was a zone of inhibition assay with E. coli strain D31 (Monner et al. 1971). Hemolymph from 
naïve, wounded and immune-challenged larvae were applied to the agar wells and the plates were 
incubated at 37 °C for 24 h. Only the hemolymph from immune-challenged larvae produced distinct 
inhibition zones (Figure 13A). 
As a second test, I carried out an initial analysis of gene expression profiles to monitor changes at the 
RNA level triggered by immune challenge, using attacin-2 mRNA as a marker because this AMP is 
known to be upregulated under similar conditions (Pöppel et al. 2015). The raw Cq values for attacin-2 
mRNA from two distinct populations, i.e. the naïve samples (Cq ~30) and the immune-challenged (Cq 
~20), are shown in (Figure 13B). No naïve sample showed a lower value than the corresponding immune-
challenged sample. These raw data supported the initial hypothesis that L. sericata attacin-2 mRNA is 
induced by immune challenge with a Gram-negative bacterium, but can only be validated by normalizing 
against the expression levels of reliable reference gene(s). 
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Figure 14: Validation of P. aeruginosa immune challenge. A: Samples of hemolymph from naïve, wounded and 
immune-challenged larvae were tested in the E. coli zone of inhibition assay, with 100 mg/ml ampicillin as a 
positive control. Only immune-challenged larvae generated a zone of inhibition. B: Distribution of quantification 
cycle (Cq) values for immune gene attacin-2 in all naïve and immune-challenged samples. Raw values for all three 
biological replicates of the six tissue and the larvae samples are displayed separately. 
4.1.5. Validation of candidate reference genes using Normfinder 
To assess reference gene expression stability a comparison among all tested genes in naïve and immune-
challenged samples is performed. This comparison of Cq variation distinguishes between systematic 
changes among samples e.g. by pipetting errors or cDNA amount and differences in gene expression 
level do to tissue type or immune-challenge. For example a deviation in cDNA amount in one sample 
pool would lead to a global uniform change for all tested genes while expression changes would differ 
among genes. An ideal reference gene would show a stable equal expression in all samples. 
The model-based Normfinder approach provides a direct estimation of variance in so-called stability 
values, with lower numbers equating a more stable expression. The program does not sequentially 
eliminate unsuitable genes so the pre-exclusion of genes with large variances is necessary to achieve 
reliable results. 
Normfinder analysis of the 10 candidate reference genes (Table 3) ranked RPS3, RPLP0 and EF1α as 
the three most stable genes considering immune challenge. The worst stability values (approximately 2-
fold higher across all samples) were observed for 18S rRNA, actin and 28S rRNA. The overall ranking 
was not transferable to all specific tissues or to whole larvae because the stability of the candidates 
differed according to the sample type. Intragroup variation was generally low with only 28S rRNA 
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showing variation (Table 10 in Sup B.2). Intergroup variation was generally much higher, with the 
highest scores generated by 18S rRNA, 28S rRNA and actin (Table 11 in Sup B.2). 
Table 3: Normfinder ranking of the stability values of candidate reference genes. 
Rank Larvae Midgut Hindgut Salivary 
glands 
Crop Fat body Nerve 
ganglion 
Overall 
1 RPLP0 EF1α RPLP0 PKA β-tubulin RPLP0 PKA RPLP0 
  (0.010) (0.010) (0.006) (0.005) (0.007) (0.006) (0.010) (0.027) 
2 actin actin EF1α RPS3 actin 18S rRNA GST1 RPS3 
  (0.017) (0.010) (0.012) (0.005) (0.011) (0.007) (0.011) (0.029) 
3 GAPDH GST1 RPS3 GAPDH PKA β-tubulin actin EF1α 
  (0.020) (0.012) (0.015) (0.014) (0.016) (0.009) (0.015) (0.029) 
4 RPS3 RPLP0 GAPDH GST1 RPS3 RPS3 18S rRNA PKA 
  (0.021) (0.014) (0.018) (0.016) (0.019) (0.013) (0.017) (0.037) 
5 GST1 PKA actin actin GAPDH PKA RPLP0 GST1 
  (0.022) (0.019) (0.020) (0.024) (0.026) (0.019) (0.022) (0.039) 
6 EF1α 18S rRNA PKA β-tubulin GST1 EF1α GAPDH GAPDH 
  (0.025) (0.020) (0.022) (0.027) (0.027) (0.036) (0.029) (0.041) 
7 PKA β-tubulin β-tubulin EF1α 18S rRNA GST1 β-tubulin β-tubulin 
  (0.026) (0.020) (0.028) (0.039) (0.030) (0.042) (0.033) (0.052) 
8 18S rRNA GAPDH 18S rRNA RPLP0 EF1α GAPDH RPS3 18S rRNA 
  (0.036) (0.021) (0.033) (0.041) (0.030) (0.044) (0.034) (0.061) 
9 β-tubulin RPS3 GST1 18S rRNA RPLP0 actin EF1α actin 
  (0.037) (0.031) (0.034) (0.057) (0.030) (0.056) (0.037) (0.068) 
10 28S rRNA 28S rRNA 28S rRNA 28S rRNA 28S rRNA 28S rRNA 28S rRNA 28S rRNA 
  (0.051) (0.074) (0.056) (0.073) (0.036) (0.131) (0.078) (0.072) 
4.1.6. Validation of candidate reference genes using GeNorm 
Thus there is no ideal algorithm for reference genes assessment a second independent approach was 
applied. The GeNorm algorithm calculates the pairwise variation among all tested genes and assigns 
stability measures (M). In every cycle, the gene with the highest stability measure (i.e. the least stable) 
is excluded until only the two best genes remain. GeNorm analysis of the 10 candidate reference genes 
(Table 4) yielded similar results to Normfinder. GeNorm ranked RPS3, RPLP0 and EF1α as the three 
best genes and 18S rRNA, actin and 28S rRNA as the three worst, with M values of 2 to 4-fold higher 
than the best candidates across all samples. As for the Normfinder data, the overall GeNorm ranking list 
was not transferable to all individual tissues or whole larvae. 
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To illustrate the differences in stability measures I also included attacin-2, which is strongly induced by 
immune-challenge and therefore expected to be unstable. As anticipated, the M value for attacin-2 was 
~20-fold higher than the most stable candidate genes in each sample (Table 4). 
Table 4: GeNorm ranking of stability measures for candidate reference genes and attacin-2. 
Rank Larvae Midgut Hindgut Salivary 
glands 
Crop Fat body Nerve 
ganglion 
Overall 
1 RPLP0 β-tubulin actin PKA β-tubulin RPLP0 EF1α EF1α 
  (0.341) (0.270) (0.128) (0.209) (0.252) (0.357) (0.241) (0.557) 
1 actin EF1α RPS3 RPS3 RPS3 RPS3 RPLP0 RPLP0 
  (0.341) (0.270) (0.128) (0.209) (0.252) (0.357) (0.241) (0.557) 
3 EF1α PKA PKA GAPDH actin β-tubulin GAPDH RPS3 
  (0.403) (0.313) (0.366) (0.514) (0.308) (0.489) (0.418) (0.841) 
4 GAPDH RPS3 RPLP0 β-tubulin GST1 18S rRNA actin GST1 
  (0.512) (0.356) (0.424) (0.522) (0.384) (0.636) (0.452) (1.164) 
5 GST1 GAPDH EF1α actin GAPDH PKA PKA GAPDH 
  (0.586) (0.427) (0.408) (0.536) (0.410) (0.778) (0.672) (1.154) 
6 18S rRNA actin GST1 GST1 PKA GAPDH GST1 PKA 
  (0.588) (0.557) (0.522) (0.620) (0.540) (0.947) (0.646) (1.219) 
7 RPS3 RPLP0 β-tubulin EF1α 18S rRNA EF1α 18S rRNA β-tubulin 
  (0.712) (0.550) (0.608) (0.685) (0.729) (0.983) (0.656) (1.266) 
8 PKA GST1 GAPDH RPLP0 EF1α GST1 β-tubulin 18S rRNA 
  (0.694) (0.547) (0.691) (0.730) (0.825) (1.015) (0.698) (1.637) 
9 β-tubulin 18S rRNA 18S rRNA 18S rRNA RPLP0 actin RPS3 actin 
  (0.817) (0.660) (0.838) (1.339) (0.859) (1.207) (0.820) (1.836) 
10 28S rRNA 28S rRNA 28S rRNA 28S rRNA 28S rRNA 28S rRNA 28S rRNA 28S rRNA 
  (1.092) (1.490) (1.229) (1.528) (0.888) (2.645) (1.658) (2.095) 
atta2 atta2 atta2 atta2 atta2 atta2 atta2 atta2 atta2 
  (6.201) (5.662) (5.874) (3.501) (5.550) (8.538) (4.569) (5.888) 
Because neither algorithm selected a single reference gene suitable for all samples, I used GeNorm 
pairwise variation comparison and select the most appropriate number of reference genes for 
normalization, which is an appropriate strategy when single reference genes are unsuitable 
(Vandesompele et al. 2002). This comparison (Vn/n+1) examines the normalization factors NFn and NFn+1 
in each analysis cycle. If the calculated value falls below a set threshold of 0.15 (Vandesompele et al. 
2002), the addition of further reference genes does not improve the quality of normalization. As shown 
in Figure 15, I found that most tissues reached the recommended threshold of 0.15 with just two reference 
genes, whereas three reference genes were required for the normalization of expression levels in the 
salivary glands (V2/3 = 0.17). When comparing overall variation, the 0.15 threshold is reached at V6/7 
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which means that six reference genes would be necessary for appropriate simultaneous normalization 
within all tested samples. 
 
Figure 15: Determination of the optimal number of control genes for normalization. Pairwise variation (Vn/n +1) 
analysis between the normalization factors NFn and NFn+1 to determine the number of reference genes required for 
accurate normalization in every individual sample group. The dashed line at 0.15 represents the set threshold below 
which the number of reference genes is optimal. 
4.1.7. Gene expression analysis after P. aeruginosa immune challenge  
To find the best set of reference genes I tried different combinations and amounts to analyze immune 
gene expression change upon P. aeruginosa challenge. The Cq values for lucimycin, defensin-1 and 
attacin-2 mRNA were therefore normalized using three combinations of candidate reference genes: (a) 
the two best candidate reference genes for every sample defined by GeNorm analysis; (b) the overall 
best three reference genes defined by both algorithms (RPS3, RPLP0 and EF1α); and (c) the overall best 
six reference genes defined by GeNorm pairwise variation comparison. My results show that the 
antifungal peptide lucimycin is not differentially expressed (Figure 16A), whereas defensin-1, which is 
specifically targeting Gram-positive bacteria, shows different upregulation in salivary glands, crop, 
nerve ganglion and fat body, ranging from a 8-fold induction in the nerve ganglion to a 290-fold 
induction in the fat body (Figure 16B). The strongest upregulation was monitored for attacin-2 that 
targets primarily Gram-negative bacteria. Attacin-2 was strongly induced by immune challenge in all 
tested tissues, ranging from a 37-fold induction in the salivary glands to a 51,463-fold induction in the 
fat body (Figure 16C). As shown in Figure 16, all three reference gene combinations lead to similar 
expression results with slight variations in relative values. 
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Figure 16: Quantitative RT-PCR analysis of lucimycin, defensin-1 and attacin-2 upon immune challenge. The 
mRNA expression of lucimycin (A), defensin-1 (B) and attacin-2 (C) was determined in different L. sericata 
tissues. Relative mRNA expression levels of individual immune genes were compared between immune-challenged 
and naïve samples and normalized with two, three or six reference genes. 
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4.2. Characterization of L. sericata Urate Oxidase 
Results presented in this section were submitted to Insect Biochemistry and Molecular Biology as 
Baumann et al. (2016). 
4.2.1. UO is expressed by Malpighian tube cells  
To identify tissue expression profile of the two purine catabolism genes UO and Allantoinase, the 3 
overall best reference gens (RPS3, RPLPO and EF1α) determined previously (see 4.1.7) were used for 
normalization. UO is predominantly expressed (>5000 x) in Malpighian tubes (Figure 17A). 
Furthermore, it is noticeable in midgut and hindgut (160 x) compared to the tissue with the lowest 
expressed (nerve ganglion). Alla shows a uniform expression profile with highest expression in crop and 
lowest in fat body (Figure 17B). Although the relative qRT-PCR quantification cannot be used to 
compare the expression of two different genes in between each other, I observed much lower signal 
strength for Alla, which had to be compensated by using 25 x more cDNA than for all other genes. This 
data indicate no correlated expression between both genes and I focused exclusively on the allantoin 
producing enzyme UO. 
 
Figure 17: Quantitative RT-PCR analysis of UO and Alla expression in L. sericata tissues. The mRNA abundance 
relative to the lowest expressed tissue for UO (nerve ganglion) and Alla (fat body) was determined using three 
reference genes (RPS3, RPLPO and EF1α). 
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Based on qRT-PCR gene expression analysis ISH was applied to visualize UO expression in Malpighian 
tubes and extended to the gut to illustrate its spatial organization. A strong UO expression was detected 
alongside most of the tube, except for the area from the gut intersection to the tube split (1) (Figure 18A). 
I observed a strict cytosolic expression leaving the nuclei unstained (Figure 18AB). No signal was 
observed inside the cells of negative control. 
I did not detect any specific signal in the gut tissue. The only signal detected there was unspecific staining 
of the gut lumen (Figure 18; 2), which can also be observed in negative controls with only hybridization 
solution (Figure 18C). Moreover, once the gut was open (Figure 18; 3) no specific signal was detected 
in gut cells thus confirming its unspecificity. 
 
 
  
Figure 18: ISH of L. sericata gut and Malpighian tubes. A: Isolated L. sericata Malpighian tubes connected to the 
gut were stained with UO probe (A+B) or negative control (C). Strong UO expression was observed inside the 
Malpighian tubes (A, B). No signal was detected in the end part of Malpighian tube connecting to the gut (1) as
well as in the gut wall (2). The unspecific binding of the hybridization solution to the gut lumen (C) was not detected 
once the gut tissue was opened (3). 
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4.2.2. Recombinant production and refolding of L. sericata UO 
L. sericata UO is a 340 amino acid enzyme with a theoretical pI of 7.73 and a molecular mass of 38.8 kDa 
that shows no precursor or export sequence. Recombinant Urate Oxidase (UOr) was produced in E. coli 
with N-terminal His6-Tag (Figure 10). Expression (Figure 19A) induction by anhydrotetracyline (1) lead 
to a clear band between 35 and 55 kDa that increased over the 3 h expression time (2-4). The inclusion 
bodies fraction was solubilized by guanidinium hydrochloride and purified via a cobalt based IMAC 
under denaturing conditions (Figure 19B) yielding 20 mg/L of enzyme. Purified enzyme was renatured 
by dialysis resulting in a single band matching the expected 40.5 kDa (*) of active enzyme (Figure 19C, 
13). Overall yield of active UOr was about 3 mg/L. 
 
Figure 19: UOr expression, purification and refolding. A: Expression was induced by anhydrotetracyline (1) and 
samples were taken after 1 (2), 2 (3) and 3 h (4). B: UOr was purified by IMAC under denaturing conditions using 
cobalt resin. Enzyme was eluted by 200 mM imidazole and individual fractions collected manually (5-11). C: 
Purified enzyme was diluted to 100 µg/ml, reduced with β-mercaptoethanol and refolded two times by dialysis 
against Tris-buffer. Refolded enzyme was analyzed via denaturing SDS-PAGE (12; protein size standard) resulting 
in a single band (*) matching the expected 40.5 kDa enzyme (13). 
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4.2.3. UOr pH and temperature optimum 
To determine crucial assay parameters UOr activity was first tested at 25 °C in the pH range of 4-10. The 
enzyme showed uniformly high activity (80-100 %) in the alkaline area with strong activity decrease 
between the pH 7 to 6.5. No activity was detected at acidic pH of 6 and below (Figure 20A). To assure 
stable color development of formed Resorufin a pH of 7.5 was chosen for all subsequent analysis. 
Temperature optimum was tested between 20-60 °C and showed highest activity at 20 and 25 °C with a 
steady activity decline towards higher temperature range and in the end no activity at 60 °C (Figure 20B). 
 
Figure 20: UOr pH and temperature dependent activity. A: UOr pH dependency was determined at 25 °C by a two 
step assay using 20 mM buffer (sodium citrate pH 4-5.5, sodium phosphate pH 6-8 or sodium borate 8.5-10) in the 
reaction step. In the quantification step the absorption at 515 nm was measured at pH 6 after 10 min and the highest 
activity was set to 100 % (n = 6). B: UOr temperature dependence was determined at pH 7.5 in the range of 20-
60 °C using continuous assay. The absorption at 560 nm was measured after 30 min and highest activity was set to 
100 % (n = 6). 
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4.2.4. UOr competitive inhibition, metal ion dependence and stability 
With pH 7.5 and 25 °C as steady parameters further tests were performed. Inhibition by the known 
competitive inhibitor 8-azaxanthine showed half maximal inhibition at a 2:1 ratio of inhibitor to substrate 
(Figure 21A). Typical alkaline earth and transition metals showed no beneficial effect on enzyme activity 
as well as the chelator EDTA that would bind available metal ions (Figure 21B). Both results confirm 
that L. sericata UO is cofactor independent as known for other UO (Fetzner and Steiner 2010). Stability 
of UOr under assay conditions (pH 7.5 and 25 °C) was monitored for a week and revealed high loss of 
activity within the first 24 h (about 50 %). Additionally UOr lost another 10 % of activity in next 6 days 
making UOr not suitable for prolonged application without further modification (Figure 21C). 
 
Figure 21: UOr competitive inhibition, metal ion dependence and stability over time. A: The competitive inhibitor 
8-azaxanthine was used in a range of 1-1000 µM against 100 µM uric acid. Inhibitor concentration was plotted 
against reciprocal activity (n = 9). B: Metal ion dependence was determined with 10 mM individual metal ions or 
50 mM EDTA for 30 min at 25 °C and H2O control activity was set to 100% (n = 9).C: Stability of UOr was tested 
for 0, 4, 24 and 168 h in 100 mM sodium chloride, 45 mM Tris-HCl, pH 7.5 at 25 °C and activity was measured 
after 30 min. Activity at 0 h was set to 100% (n = 6). 
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4.2.5. Native UO is exclusively present in Malpighian tubes 
The detection of UO on protein level was facilitated by western blot analysis. Same larval tissues as for 
qRT-PCR (midgut, hindgut, salivary glands, crop, fat body, Malpighian tubes and nerve ganglion) 
supplemented by maggot secretory and excretory products (E/S) were tested. All samples were resolved 
by reducing SDS-PAGE and stained by coomassie (Figure 22A). Specific UO antibody (see 3.4.1) was 
apply to detect the native enzyme in individual tissues. As shown in Figure 22B I detected strong signal 
around 40.5 kDa in Malpighian tubes, while no signal was detected in any other tissue. The size of the 
detected band corresponds to the theoretical molecular weight of UO (38.8 kDA). 
 
Figure 22: Coomassie staining and UO detection by western blot in L. sericata tissues and E/S. A: Coomassie 
staining after denaturing SDS-PAGE of L. sericata tissues and E/S samples. Sample amount of 5-15 µl was 
estimated to yield clear band patterns. B: Equal sample amounts to A were used for western blot with anti-UO 
antibodies and visualized by HRP conjugated secondary antibody via chemiluminescence. Ladder was post stained 
with coomassie on polyvinylidene difluoride (PVDF) membrane. 
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Immunolocalization of native UO in Malpighian tubes using specific UO antibody and whole mount 
staining, clearly demonstrate the presence of native UO inside the Malpighian tube cells. A strong UO 
signal was observed in various cells along the whole tube with no signal at the intersection to the gut (1) 
and very weak or no signal in the gut tissue itself (Figure 23A). On single cell resolution I detected strict 
cytosolic localization of UO showing no sign of accumulation in vacuole like structures (Figure 23B). 
Pre-immune serum was used as a negative control (Figure 23C). 
 
 
 
 
Figure 23: Whole mount staining of L sericata gut and Malpighian tubes. Isolated L. sericata Malpighian tubes
connected to the gut (1) were stained with anti-UO antiserum (A+B) or pre-immune serum (C) and visualized with
an Alexa488 conjugated secondary antibody (green). Nuclei were counterstained with 4',6-diamidino-2-
phenylindole (DAPI) (blue). 
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5. Discussion 
L. sericata larvae applied during MDT have various beneficial effect on wound healing and their E/S 
represents a potential rich source of novel therapeutic compounds. To validate and narrow down 
candidate genes from transcriptome datasets qRT-PCR is a fast, precise and cheap approach, but relies 
highly on appropriate reference genes for the normalization of gene expression data. Those qRT-PCR 
results, enabled by appropriate reference genes, are the first step to gain better understanding of MDT 
from a basis research perspective as discussed in 5.1 and 5.2. Another challenge in insect enzyme 
research is the isolation of sufficient amount of highly pure enzymes for detailed analysis. This can be 
overcome by heterologous production of recombinant enzymes. Production of L. sericata recombinant 
enzymes seems to be an ideal approach, from an applied perspective as discussed in 5.3, to evaluate the 
medical and biotechnological potential of L. sericata candidate enzymes. 
5.1. L. sericata reference gene assessment 
Results of this thesis, published under Baumann et al. (2015), investigated the tissue specific expression 
stability of 10 candidate reference genes and 3 immune genes (lucimycin, defensin-1 and attacin-2), 
which target various pathogen classes. I monitored the expression of these immune genes in different L. 
sericata tissues before and after the immune challenge with the Gram-negative bacterium P. aeruginosa, 
which was introduced into third-instar L. sericata larvae by pricking its dorsal part with a contaminated 
needle. Such an artificial infection far exceeds the intensity of the bacterial challenge that maggots 
encounter in human wounds. I am aware of the fact that this method leads to a higher variation in bacterial 
concentration compared to e.g. microinjection, but due to the high maggot motility a gentle restraining 
with modelling clay or more efficient one with tape were almost impossible. In both cases I faced a high 
number of escaping animals or high mortality due to drying out and/or ripping. Consequently hand 
pricking also introduces an increased variation in injection location targeting not only the hemolymph, 
but possibly also some tissues. Such an approach is not most suitable for an experimental setup that 
demands high reproducibly to get reliable results, but in this case the goal was to assess reference gene 
stability under harsh conditions thus this increase in variation is beneficial to robustly test the stability 
of the candidate reference genes. 
  
The strongest expression after such an immune challenge was observed for attacin-2 (targeting Gram-
negative bacteria (Imler and Bulet 2005)). Attacin-2 was monitored in all larval tissues reaching its 
maximum in fat body (over 50,000-fold). No differential expression was observed for the antifungal 
peptide lucimycin, which is known to have no effect against Gram-negative bacteria (Pöppel et al. 2014). 
Interestingly, defensin-1 as a representative targeting Gram-positive bacteria (Imler and Bulet 2005), was 
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differentially upregulated in salivary glands, crop, nerve ganglion and fat body (Figure 16B). This 
unexpected result can be easily explained by the wounding procedure itself, which has been shown to 
induce insect immune response previously (Han et al. 1999). My results demonstrate that even under 
such harsh conditions, which heavily perturbed the system and led to the strong induction of attacin-2, 
the expression of most of the candidate reference genes remained stable. This success rate reflects the 
smart choice of reference gene candidates that have been already applied as references in other insects, 
allowing for a knowledge-based pre-selection of candidates that are likely to be suitable as reference 
genes in L. sericata (Bagnall and Kotze 2010; Ponton et al. 2011; Scharlaken et al. 2008; Sun et al. 2015; 
Toutges et al. 2010; Yuan et al. 2014). 
The Normfinder and GeNorm algorithms (Table 3 and 4) were unable to identify a single optimal 
reference gene or an ideal combination of two to three reference genes that worked consistently across 
all tested tissues. RPLP0, EF1α and RPS3 were identified as the most stable reference genes across all 
samples even though each of them ranked low for stability in at least one of these samples. All three 
genes are involved in protein expression (Meriin et al. 2012; Polakiewicz et al. 1995; Rich and Steitz 
1987) and a co-regulation cannot be completely ruled out as an explanation for their high ranking. 
However, comparison with the other candidate genes does not indicate generally co-regulated 
expression. Although it may be necessary to use specific gene candidates for particular tissues to achieve 
the most accurate data normalization, the use of these three overall best reference genes should be more 
than adequate for most experimental scenarios, as illustrated by my expression analysis of three immune 
genes (Figure 16). 
Among the remaining candidates, genes some (e.g. GST1 and GAPDH) occupy mid-ranking positions 
in many tissues and have poor scores in others but never rank as the most suitable reference gene, whereas 
others (e.g. PKA and β-tubulin) also occupy mid-raking position in many tissues but are the most stable 
reference genes in others, i.e. the salivary glands and the nerve ganglion (PKA) or the crop (β-tubulin). 
Their overall mid-to-low ranking reflects their tendency to show good scores in a few tissues but poor 
scores in most others (Table 3 and 4). 
Remarkably, actin has a low overall score but good scores in several tissues (second most stable reference 
in three tissues and third in another). However, the standard deviation of 2.1 Cq is the highest among all 
the tested candidate genes (Figure 13), reflecting high intergroup variation (Table 11 in Sub B.2) rather 
than changes in expression induced by the immune challenge, which would lead to higher intragroup 
variations (Table 10 in Sub B.2). It is not surprising that a fundamental structural protein like actin would 
be expressed at different levels in diverse tissues such as the gut and the fat body. Therefore, despite its 
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low overall ranking, actin would be useful as a reference gene in most individual tissues but not in more 
diverse collections of samples. 
Compared to the other candidates, the genes for 18S and 28S rRNA were the least stable and therefore 
the least suitable for normalization, which contrasts with the findings in other arthropods (Bagnall and 
Kotze 2010; Majerowicz et al. 2011). This may be a species-dependent phenomenon, but may also reflect 
the technical approach, e.g. the method used for RNA isolation and cDNA synthesis. For example, I used 
oligo(dT)18 primers which only partly reverse transcribe the rRNA genes due to the lack of a canonical 
polyadenylate tail. 
While dissecting the fat body from immune-challenged larvae I observed the remodeling and/or 
degradation of this tissue. The physical appearance of the fat body changed from clusters of round cells 
to loosely-associated amorphous cells which yielded lower amounts of total RNA with poorer quality 
compared to the other tissues. After immune challenge, fat body total RNA from all biological replicates 
had to be precipitated and concentrated to meet the required criteria for cDNA synthesis. The insect fat 
body is responsible for AMP production (Hetru et al. 2003) and two defense pathways have been 
described in Drosophila melanogaster, i.e. the Toll pathway against Gram-positive species and the 
immune deficiency (IMD) pathway against Gram-negative species (Hoffmann and Reichhart 2002). 
Constitutive triggering of the IMD pathway has been shown to induce apoptosis (Georgel et al. 2001). 
My results show that although attacin-2 is expressed ubiquitously and globally upregulated by immune 
challenge, the strongest induction (over 50,000-fold) occurs in the fat body (Figure 16C). I used P. 
aeruginosa, which as a Gram-negative species is targeted by attacins (Imler and Bulet 2005) and 
hypothesize that the IMD pathway plays a major role in this immune response. The induction of attacin-2 
may therefore be part of this IMD pathway response, ultimately resulting in apoptosis which may explain 
the physical changes in the fat body I observed. 
Analysis of qRT-PCR expression data without normalization is impossible, because of variations in 
extraction yield, reverse-transcription yield, efficiency of amplification and other systemic variations 
like e.g. variation in pipetting that are inherent to all biological experiments (Bustin et al. 2009; Nolan 
et al. 2006). For such a precise method that can even detect low copy number targets the use of only a 
single reference gene is  widely accepted as being insufficient (Gutierrez et al. 2008; Nolan et al. 2006). 
The demand for accurate normalization of gene expression data by validated reference genes for relative 
comparison of gene expression data let to several statistical algorithms (Andersen et al. 2004; Pfaffl et 
al. 2002; Vandesompele et al. 2002). 
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There is probably no universally ideal reference gene in any experimental system so it is important to 
distinguish between the best gene and combination of genes suitable for different experimental settings. 
Despite the diverse expression profiles of the 10 candidate reference genes in the dissected tissue 
samples, several combinations of these genes gave identical results when used for the normalization of 
immune genes expression during an immune challenge, suggesting that the analysis of six reference 
genes per sample or different reference genes in each tissue is unnecessary. From my own experience, 
the reliable normalization of L. sericata expression data among all dissected tissues (Figure 16) is also 
achieved using the three best reference genes based on the overall rankings (RPLP0, EF1α and RPS3), 
which balances accuracy with convenience and the cost of additional experiments. The primer pairs and 
reference gene candidates evaluated in this thesis provided a valuable tool for the normalization of gene 
expression data in medical maggots, which will facilitate the identification and functional analysis of 
genes which are responsible for the beneficial effects of MDT. Furthermore reliable L. sericata reference 
genes are in demand in Forensic entomology. Nowadays genetic analysis to determine the exact species 
of found larvae and pupal are already established and save valuable time, because insect do not need to 
be grown in the lab until adult stage to determine the species by visual analysis (Amend 2004). 
Transcriptional analysis will boost accuracy in PMI determination even further especially for post 
feeding 3rd instar larvae and pupae. Developmental genes allowing this are under investigation and 
depend an accurate normalization of results by reliable reference genes (Boehme et al. 2013; Tarone and 
Foran 2011; Tarone et al. 2011). 
5.2. UO and purine catabolism 
Results submitted under Baumann et al. (2016) (Insect Biochemistry and Molecular Biology) I 
investigated L. sericata UO and its relations in purine catabolism. The L. sericata transcriptome (Franta 
et al. 2016) was used to identify enzymes involved in purine catabolism and thus nitrogen waste 
management. Further on the detailed expression analysis in individual larval tissues was performed via 
qRT-PCR using previously evaluated L. sericata reference genes. A gene encoding for Urate Oxidase, 
an unique enzyme responsible for allantoin production, was produced recombinantly and its native form, 
as well as RNA signal was detected in larval tissues using specific UO antibodies or ISH respectively. 
These data broaden our knowledge about the molecules involved in MDT and indicate that also secretion 
products play a beneficial roles in MDT. 
Insects are the biggest and most diverse group of animals and their species diversity is also reflected in 
the variety of nitrogenous waste products. Spanning the whole scale from the house cricket Acheta 
domesticus excreting mainly uric acid (Nation and Patton 1961), through all related purine metabolites 
(Bursell 1967) down to the American cockroach Periplaneta Americana, which is excreting mainly 
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ammonia (Mullins and Cochran 1972). Exploring L. sericata transcriptome identified only one gene 
encoding for both UO and Allantoinase, but no genes encoding for Allantoicase and/or Urease, 
respectively. Using qRT-PCR and ISH I show that UO is predominantly expressed in Malpighian tubes 
(Figure 17A).This result is in accordance with studies in mosquito Aedes aegypti and fruit fly Drosophila 
melanogaster where UO is also mainly expressed in Malpighian tubes (Scaraffia et al. 2008; Wallrath et 
al. 1990). Allantoinase, on the other hand, shows equal expression in various tissue (Figure 17B), thus 
excluding its necessary co-localization with UO. However qRT-RCR only enables relative comparisons 
of one gene and not among different genes, my observation that 25 times more cDNA is needed for 
Allantoinase compared to UO to get a similar signals for both genes is a clear hint for much lower 
abundance of L. sericata Allantoinase. 
UO activity has been previously detected in various insect species, while Allantoinase activity could 
only be estimated for a few insect species due to the presence of allantoic acid (Bursell 1967). In L. 
sericata no allantoic acid was detected (Brown 1938) and this finding together with my results indicates 
no direct degradation of allantoin down to urea by L. sericata. Urea present in chronic wounds could be 
a result of subsequent degradation of allantoin by gut associated microbiota. This phenomenon is well 
known for other insects (Jurkevitch 2011; Lauzon et al. 2000), and is also indicated by the transcriptome 
search. Another explanation of urea presence in the wound could be due to its production by Arginase 
an enzyme that creates urea by hydrolysing the arginine side chain (von Dungern and Briegel 2001). 
The antibody based detection of L. sericata UO on protein level shows the same trend as monitored for 
the UO gene expression (Figure 22 and 23). I detect native UO exclusively inside Malpighian tube cells 
and not in any other tissue nor in E/S as assumed previously (Brown 1938). Moreover, my results show 
that L. sericata UO enzyme is not present in any vacuole but rather freely available in the cell cytoplasm 
(Figure 23B). This finding groups insect UOs with bacterial and fungal counterparts (e.g. Bacillus 
fastidiosus or Fusarium oxysporum) that are soluble and in contrast to the mammalian and other 
vertebrate UOs not cluster with other purine catabolism enzyme in peroxisomes (Vogels and Van der 
Drift 1976; Volkl et al. 1988). My findings indicate that allantoin is excreted as a primal waste product 
of nitrogen disposal of L. sericata. Presence of allantoin and other substances such as ammonium 
bicarbonate or urea are believed to maintain the wound pH in the alkaline (Fleischmann et al. 2004), 
which is crucial for activity of L. sericata digestive proteases during debridement (Chambers et al. 2003). 
As the wound proceed towards the healing process, the wound pH shifts from alkaline to neutral until it 
reaches the acidic pH of healthy skin (Gethin 2007). During the healing and remodeling phase allantoin 
was shown to be involved in the hastened healing (Araujo et al. 2010; DiSalvo 2002). 
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My localization of L. sericata UO on mRNA as well as protein level in different L. sericata tissues show 
its exclusive localization inside the Malpighian tube cells (Figure 17, 18, 22 and 23). Allantoin is 
produced by UO to remove uric acid from the insect hemolymph, which is finally excreted via the 
hindgut as nitrogenous waste product. My findings show that not only actively secreted molecules, but 
also excretion products contribute to the beneficial effects of MDT. 
5.3. UOr and application potential 
Submitted under Baumann et al. (2016) (Insect Biochemistry and Molecular Biology) I utilize the L. 
sericata UO sequence data as well to produce the enzyme recombinantly. I am the first to produce and 
characterize an insect UO, an enzyme that creates allantoin, which contributes to the wound healing 
process (Araujo et al. 2010; DiSalvo 2002). I produced UOr in E. coli, purify it via IMAC and test for 
it´s pH optimum, temperature optimum, competitive inhibition, cofactors and stability (Figure 20 and 
21). 
UOr is cofactor independent which is a typical feature for this class of enzymes (Fetzner and Steiner 
2010). As well as the inhibition by the know competitive inhibition 8-azaxanthine (2:1 ratio) (Colloc'h 
et al. 1997). It has a temperature optimum around 20-25 °C, this suits to an enzyme localized inside the 
larvae, which have a standard rearing temperature of 28 °C (Shiravi et al. 2011). It would also be active 
in the wound bed, which shows a temperature of 33 °C (like the skin) or above (Dini et al. 2015) and 
even in an internal application at 37 °C the enzyme would still show an activity of 70%. The pH optimum 
in the alkaline is also in agreement with the internal pH in insect Malpighian tubes and cells that is 
slightly above 7 (Petzel et al. 1999). Below pH 7 UOr activity steeply declines and shows no activity at 
pH 6 and below. From an application point of view the pH profile is unfavorable. The enzyme would be 
active in the alkaline early wound stages, but not in the final healing phase where the pH is shifted back 
to the acidic (Gethin 2007) and in that phase the produced allantoin would be beneficial to hasten the 
healing process. 
Allantoin is in use for cosmetics and topical pharmaceuticals for over 70 years. It is FDA classified as 
Category I (safe and effective) as an active ingredient for skin protection. Its keratolytic (softens skin) 
properties without any adverse effects (e.g. no skin irritation) made it a part of many cosmetics (AKEMA 
fine chemicals; www.akema.it). Remarkable for a substance with assumed healing properties that is in 
wide use for so long there are no studies that quantify the beneficial effects or investigate the specific 
mechanism. The first study proving the healing properties of allantoin was published in 2010 (Araujo et 
al. 2010). One explanation for the lack of studies is originated in the production of allantoin. It can be 
chemically synthesized by uric acid oxidation with permanganate. A method that was invented by Liebig 
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and Wöhler (1837) and an important source for allantoin in the 1930s. Nowadays a major source are 
extracts of the comfrey plant (Symphytum officinale), their roots and herbs contain 0.6-1 % allantoin 
(Staiger 2012). Most studies and cosmetic use those plant extract and thus observed effects do not solely 
originate from allantoin and can not be attributed to a single component (Araujo et al. 2012). 
Due to the dysfunctional human UO there are several health complications related to high level of uric 
acid in humans. Tumor lysis syndrome (TLS) is such an example, where high amounts of uric acid flush 
the human body due to cell lysis during chemotherapy. Rasburicase a recombinant UO originating from 
fungus Aspergillus flavus was approved by FDA for TLS application in 2009 (Ueng 2005). A. flavus UO 
was at first homolog expressed and marketed as Uricozyme, but due to severe allergic reactions 
discontinued. Rasburicase is nowadays expressed in Saccharomyces cerevisiae (Garay et al. 2012) and 
E. coli expression in soluble active form was also proven possible (Legoux et al. 1992). Recombinant 
Rasburbicase lowers plasma uric acid levels prior to chemotherapy thus preventing acute renal failure 
and ultimately death of patients, but its application still results in high prevalence (15-24 % patients) of 
allergic reaction or antibodies development (Goldman et al. 2001). 
For long term reduction of plasma uric acid levels to prevent uric acid precipitations (tophi) or reduce 
the effects of chronic gout allopurinol is the current standard treatment. This competitive inhibitor of 
Xanthine Oxidase reduces the synthesis of uric acid. It is oral bioavailable, but requires longer time than 
UO treatment to show effects and several years to dissolute tophi (Perez-Ruiz and Liote 2007). Several 
recombinant UOs have been tested for long term applications like treatment failure gout failure. The 
standard treatment (allopurinol) shows no more effect in long term treatment or causes an immunogenic 
reaction, but without positive outcome. Krystexxa (Pegloticase) is a PEGylated chimeric Pig-Baboon 
UO. The polyethylene glycol (PEG) conjugation masks the enzyme surface, thus reducing antigenicity 
and prolonging enzyme half-life (Jevsevar et al. 2010). This first recombinant mammalian UO combines 
the highly active porcine UO with the C-terminal baboon UO sequence to further reduce immunogenicity 
(Ganson et al. 2006). The urgent need for any alternative in treatment failure gout led to FDA approval 
(2010) of Krystexxa (Sundy et al. 2011; Sundy and Hershfield 2007), even if it resulted in serious adverse 
effects in 18 % of patients. 
Over the last 40 years many improvements in UO production, activity and stability were made, but the 
adverse side effects of all tested recombinant UOs creates a demand for new, active UOs with low 
immunogenicity, which could be successfully applied in long term treatments. One interesting approach 
to overcome immunoreactivity is to reactivate human UO by ancestral sequence reconstruction (Kratzer 
et al. 2014). Another possible solution could be offered by insect UOs.  
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5.4. Outlook 
The qRT-PCR approach established during this thesis allows the tissue specific expression analysis of 
candidate genes in immune challenge experiments and provides reliable L. sericata reference genes for 
normalization of those data. It was already applied in the identification and validation of genes encoding 
for various proteases from maggots (Franta et al. 2016; Pöppel et al. 2016), thus improving our 
understanding of MDT and contributing to the transformation from classic maggot therapy to modern 
biosurgery. Furthermore the reference genes could contribute in forensic entomology to boost accuracy 
in PMI determination. Transcriptional analysis especially for post feeding 3rd instar larvae and pupae 
would not only safe time by making rearing unnecessary, but could also be more precise and especially 
for this reference genes are needed to obtain accurate results. 
 
The L. sericata Urate Oxidase produced and characterized during this thesis is the first insect UO 
expressed heterologously and analysed in detailed manner. From a basic research point of view those 
findings improve our understanding of MDT. From an application point of view UOr would need to 
undergo severe further modifications to improve its overall stability, catalytic activity and solubility. 
Catalytic activity could be improved by a different expression strategy that has a higher chance of 
yielding soluble enzyme. By this the enzyme might differ in folding and could be more active. One 
option would be the cry-tag (Hayakawa et al. 2010) the other a host like yeast or insect cells (Spohner et 
al. 2016; Zitzmann et al. 2017). Another option could be to improve catalytic activity systematically by 
a directed evolution strategy followed by rational site directed mutagenesis of promising amino acids 
positions determined before (Packer and Liu 2015). To increase enzyme stability the introduction of an 
additional Cysteine recently identified in zebra fish UO would also be an option (Marchetti et al. 2016). 
This Cysteine residue was shown to promote inter monomer linkage and thus increased the stability of 
the active homotetramer. Additionally PEGylation could improve in vivo stability of the enzyme. A 
promising approach that would overcome the solubility issues and increase stability while also reducing 
immunogenicity would be the immobilization of UO on nanoparticles like fumed silica (Cruz et al. 
2011). If the immunogenicity of those nanoparticles itself is low the restricted access inside the particles 
could mask the enzyme from the immune system and be a promising approach for long term applications. 
 
Insects, especially their secretions, venoms but also other products (e.g. honey) are finding its way into 
modern western medicine (Cherniack 2010) with L. sericata maggots and honey bees as the vanguard of 
this field. Several clinical trials prove the beneficial effects and healing potential of insect compounds, 
but their majority is strictly limited in both amount of active substance as well as strict topical application 
(McIntosh and Thomson 2006; Steenvoorde et al. 2007). Recombinant production of insect derived 
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enzymes could overcome this problem by providing sufficient amount of pure enzymes, which can be 
applied either single or in combination with other substances in both modern biomedicine and 
biotechnology. 
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Abbreviations 
 °C Degree Celsius  
4-AAP 4-amino-antipyrine 
bp Base pair 
BSA Bovine serum albumin 
cDNA Complementary deoxyribonucleic acid 
Cq quantification cycle 
DAPI 4, 6-Diamidino-2-phenylindole 
ddH20 Double-distilled water 
DCHBS 3,5-dichloro-2-hydroxybenzene sulfonic acid 
DEPC Diethylpyrocarbonate 
DNA Deoxyribonucleic acid 
DSM German Collection of Microorganisms and Cell 
Cultures 
dT Deoxy-thymidine nucleotides 
E/S secretions and excretions 
E. coli Escherichia coli 
EDTA Ethylenediamine tetraacetic acid 
Fc Final concentration 
Fwd Forward 
g Relative centrifugal force 
h hour 
His6-Tag Hexa-Histidine-Tag 
HRP horseradish peroxidase 
i.a. Inter alia 
IMAC Immobilized Metal Affinity Chromatography 
LB Lennox Broth 
M Mol/l 
min minute 
P. aeruginosa Pseudomonas aeruginosa 
p.a. Analytical grade 
PEG polyethylene glycol 
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PBS Phosphate buffered saline 
PVDF Polyvinylidene difluoride 
qRT-PCR Quantitative reverse transcription polymerase 
chain reaction 
Rev Reverse 
RNA Ribonucleic acid 
RT Room temperature 
TB Terrific Broth 
TBS Tris buffer saline 
Tm Melting temperature 
V Volt (kg·m2·s−3·A−1) 
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Supplement A: Materials 
A.1 Chemicals and reagents 
Table 5: Chemicals and reagents 
Substance Vendor Catalog number 
β-mercaptoethanol  Bio-Rad, Hercules, US 161-0710 
3,5-dichloro-2-hydroxybenzene 
sulfonic acid 
Sigma-Aldrich, Munich, Germany D4645-5G 
4,6-Diamidino-2-phenylindole 
(DAPI) 
Sigma-Aldrich, Munich, Germany 32670 
4-amino-antipyrine Carl Roth, Karlsruhe, Germany 2671.1 
8-azaxanthine Sigma-Aldrich, Munich, Germany 11460-1G 
Acetic acid Carl Roth, Karlsruhe, Germany 3738.4 
Agar-Agar, bacteriological Carl Roth, Karlsruhe, Germany 2266.2 
Ampicillin sodium salt Carl Roth, Karlsruhe, Germany K029.2 
Anhydrotetracyline Sigma-Aldrich, Munich, Germany 94664 
Aqua-Poly/Mount Polysciences, Hirschberg an der 
Bergstrasse, Germany 
18606-20 
BL21(DE3) Competent E. coli  New England Biolabs, Ipswich, US C2527H 
Boric acid Carl Roth, Karlsruhe, Germany P010.1 
Bromphenol blue Carl Roth, Karlsruhe, Germany A512.1 
Bovine Serum Albumin Sigma-Aldrich, Munich, Germany A9418 
Calcium chloride Carl Roth, Karlsruhe, Germany T885.2 
Citric acid Carl Roth, Karlsruhe, Germany X863.2 
Columbia Agar with Sheep 
Blood PLUS 
Thermo Scientific Oxoid, Schwerte, 
Germany 
10516583 
Diethylpyrocarbonate Carl Roth, Karlsruhe, Germany K028.1 
Di-Sodium hydrogen phosphate Carl Roth, Karlsruhe, Germany 4984.2 
Ethanol 100 % (p.a.)   Carl Roth, Karlsruhe, Germany 9065.2 
Ethylenediamine tetraacetic acid 
(EDTA) 
Carl Roth, Karlsruhe, Germany CN06.1 
Formamide  Sigma-Aldrich, Munich, Germany F-9037 
Glycerol Carl Roth, Karlsruhe, Germany 3783.2 
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Glycin Carl Roth, Karlsruhe, Germany 3908.3 
goat anti guinea pig F(ab')2 
fragment Alexa488 conjugate 
antibody  
Dianova, Hamburg, Germany 106-546-003 
goat anti guinea pig F(ab')2 
fragment HRP conjugate 
antibody 
Dianova, Hamburg, Germany 106-036-003 
Guanidine hydrochloride Carl Roth, Karlsruhe, Germany 0037.1 
Heparin Sigma-Aldrich, Munich, Germany H-3393 
Horseradish peroxidase  Sigma-Aldrich, Munich, Germany P8375-5KU 
Imidazole Sigma-Aldrich, Munich, Germany 3899.3 
L. sericata larvae BioMonde GmbH, Barsbüttel, 
Germany 
4701521 
LB Broth (Lennox) Carl Roth, Karlsruhe, Germany X964.3 
Magnesium chloride Carl Roth, Karlsruhe, Germany 2189.2 
Mini-PROTEAN TGX Gel 
4-15 %  
Bio-Rad, Hercules, US #456-1084 
Manganese(II) chloride Sigma-Aldrich, Munich, Germany 244589 
Sodium hydroxide Carl Roth, Karlsruhe, Germany 6771.1 
Nickel(II) sulfate Sigma-Aldrich, Munich, Germany 31483 
Nitroblue tetrazolium and 
bromo-chloro-indolyl-
phosphate solution 
Roche, Mannheim, Germany 11681451001 
Paraformaldehyde (16%)  Polysciences, Hirschberg an der 
Bergstrasse, Germany 
18814 
pASK IBA37plus IBA, Göttingen, Germany 2-1437-000 
Proteinase K Sigma-Aldrich, Munich, Germany P2308 
Qiagen Blocking Reagent Qiagen, Hilden, Germany 34460 
RNAse free H2O Macherey-Nagel, Weilmünster, 
Germany 
740955.50 
Roti-Blue quick Carl Roth, Karlsruhe, Germany 4829.2 
Roti-ImmunoBlock Carl Roth, Karlsruhe, Germany T144.1 
Saline-sodium citrate (5 x) Sigma-Aldrich, Munich, Germany S-6639 
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Salmon testes DNA Sigma-Aldrich, Munich, Germany D-7656 
Sheep anti-digoxigenin antibody 
alkaline phosphatase (AP)-
labelled 
Roche, Mannheim, Germany 11093274910 
Sodium acetate (RNAse free) Fisher Scientific, Schwerte, 
Germany 
#R1181 
Sodium chloride Carl Roth, Karlsruhe, Germany 9265.2 
Sodium dihydrogen phosphate Carl Roth, Karlsruhe, Germany T879.2 
Sodiumdodecylsulfate ultra pure 
(SDS) 
Carl Roth, Karlsruhe, Germany 2326.1 
SYBR Green PCR Master Mix Applied Biosystems, Foster City, 
US 
4367659 
SYBR Safe Thermo Scientific, Schwerte, 
Germany 
S33102 
TALON resin  Clontech, Mountain View, US 635504 
Terrific broth medium Carl Roth, Karlsruhe, Germany X972.3 
Tris-Base Carl Roth, Karlsruhe, Germany AE15.3 
Tris-HCl Carl Roth, Karlsruhe, Germany 9090.3 
Trisodium citrate Carl Roth, Karlsruhe, Germany 4088.3 
Triton X-100 Carl Roth, Karlsruhe, Germany 3051.3 
Tween 20 Carl Roth, Karlsruhe, Germany 9127.1 
Urea Carl Roth, Karlsruhe, Germany 3941.2 
Uric acid Carl Roth, Karlsruhe, Germany 4999.1 
Xylene cyanole Carl Roth, Karlsruhe, Germany A513.1 
Zinc chloride Sigma-Aldrich, Munich, Germany 7646-85-7 
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A.2 Consumables 
Table 6: Consumables 
Consumables Vendor Catalog number 
96-well plate (qRT-PCR). Applied Biosystems, Foster City, 
US 
4346906 
96-well plate 
(spectrophotometer) 
Greiner Bio-One, Frickenhausen, 
Germany 
655185 
Bioreactor 50 TubeSpin, Trasadingen, 
Switzerland 
87050 
Eppendorf tube 1,5 ml Eppendorf, Hamburg, Germany 0030 120-086 
Falcon tube 50 ml Greiner Bio-One, Frickenhausen, 
Germany 
227261 
Fine tip tweezers (Type 5, 
Dumont) 
Carl Roth, Karlsruhe, Germany 
Roth 
TE73.1 
Forceps made of spring steel Carl Roth, Karlsruhe, Germany 
Roth 
AL99.1 
Metal pestle Carl Roth, Karlsruhe, Germany 
Roth 
YE14.1 
Microscope slide (diagnostic 3 
cambers) 
Carl Roth, Karlsruhe, Germany 
Roth 
L196.1 
Needle 0.5 x 16 mm B.Braun, Melsung, Germany 4658302 
Petri dishes (94 x 16 mm) Greiner Bio-One, Frickenhausen, 
Germany 
633180 
PVDF membrane Merck Millipore, Billerica, US P2938 
96-well plate 
(spectrophotometer) 
Greiner Bio-One, Frickenhausen, 
Germany 
655185 
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A.3 Devices 
Table 7: Devices 
Device Vendor 
Binocular microscope, No813522 Will, Wetzlar, Germany 
Centrifuge, Mikro 220R Hettich Tuttlingen, Germany 
Centrifuge, Rotina 420R Hettich Tuttlingen, Germany 
Eon microplate spectrophotometer BioTek, Bad Friedrichshall, Germany 
Hybridization oven, Memmert UNB 500  Memmert, Schwabach, Germany 
Incubator, Heraeus Oven Typ T6 Thermo Scientific, Schwerte, Germany 
Leica Mz16 F microscope Leica Microsystems, Wetzlar, Germany 
Leica TCS SP8 confocal microscope Leica Microsystems, Wetzlar, Germany 
Mini-PROTEAN Tetra System Bio-Rad, Hercules, US 
MP110PS high pressure microfluidiser Microfluidics, Newton, US 
Photometer, Specord 210 Analytik Jena, Jena, Germany 
Purified water system, TKA-GenPure Thermo Scientific, Schwerte, Germany 
SE-04 FPLC system ECOM, Prague, Czech Republic 
Shake incubator, Multitron II INFORS HAT, Bottmingen, Switzerland 
StepOnePlus Real-Time PCR System Applied Biosystems, Foster City, US 
Take3 plate microdrop reader BioTek, Bad Friedrichshall, Germany 
TransBlot Turbo Transfer System Bio-Rad, Hercules, US 
Versadoc Imaging System Bio-Rad, Hercules, US 
Water bath, Microprocessor control MPC Huber, Offenburg, Germany 
A.4 Standards and kits 
Table 8: Standards and kits 
Kit Vendor Catalog number 
Amplex Red Uricase Assay Kit Fisher Scientific, Schwerte, 
Germany 
A22181 
BCA Protein Assay Kit Thermo Scientific Pierce, 
Schwerte, Germany 
23227 
First Strand cDNA Synthesis 
Kit 
Thermo Fisher Scientific, 
Schwerte, Germany 
K1682 
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Lumi-LightPLUS Western 
Blotting Substrate 
Roche, Mannheim, Germany 12015196001 
NucleoSpin RNA Kit Macherey-Nagel, Weilmünster, 
Germany 
740955.50 
PageRule Plus Prestained 
Protein Ladder 
Thermo Scientific Fermentas, 
Schwerte, Germany 
26619 
PCR DIG Probe synthesis kit Roche, Mannheim, Germany 11636090910 
Penta·His HRP Conjugate Kit Qiagen, Hilden, Germany 34460 
A.5 Buffer and solutions 
Table 9: Buffers and solutions 
Name Composition 
AP buffer 100 mM Tris-Base, 100 mM NaCl, 50 mM MgCl2, 0.1 % Tween 20, 
pH 9.5 
Chaotropic buffer 8 M guanidine hydrochloride, 30 mM Tris, pH 7.5 
Dialysis buffer (1 x) 20 mM Tris-Base, 150 mM NaCl, pH 7.5 
IMAC buffer A 6 M urea, 30 mM Tris-Base, 100 mM NaCl, pH 7.5 
IMAC buffer B 6 M urea, 30 mM Tris-Base, 100 mM NaCl, 200 mM imidazole, pH 
7.5 
Laemmli-buffer (1 x) 62.5 mM Tris-HCl, 2 % SDS, 10 % Glycerol, 2 % β-
mercaptoethanol, 0.005 % Bromophenol blue, pH 6.8 
Lysis buffer 30 mM Tris-Base, 100 mM NaCl, pH 7.5 
Phosphate buffer saline (PBS) 0.01 M phosphate buffer, 0.0027 M potassium chloride, 0.137 M 
sodium chloride, pH 7.4 (Sigma-Aldrich P44170) 
RA1 buffer Component of NucleoSpin RNA Kit (Macherey-Nagel 740955) 
consisting of chaotropic salt. 
RNA loading buffer (5 x) 8 M urea, 0.5 mM EDTA, 0.1 % Bromphenol blue, 0.1 % Xylene 
cyanol 
TAE buffer (1 x) 40 mM Tris-Base, 20 mM acetic acid, 1 mM EDTA, pH 8.3 
TBST-buffer (1 x) 50 mM Tris-Base, 150 mM NaCl, 0.1 % Tween 20, pH 7.4 
Tris-buffer saline (TBS) (1 x) 50 mM Tris-Base, 150 mM NaCl, pH 7.4 
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Supplement B: Support information 
B.1 Melt curves of all applied qRT-PCR primer pairs. 
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Figure 24: Melt curves of all applied qRT-PCR primer pairs. 
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B.2 Normfinder intra and intergroup variations 
Table 10: Normfinder intragroup variation for all candidate reference genes. 
Gene Larvae Midgut Hindgut Salivary 
glands 
Crop Fat body Nerve 
ganglion 
18S rRNA 0.001 0.000 0.001 0.003 0.001 0.000 0.000 
28S rRNA 0.003 0.005 0.003 0.005 0.001 0.017 0.006 
RPS3 0.000 0.001 0.000 0.000 0.000 0.000 0.001 
EF1α 0.001 0.000 0.000 0.002 0.001 0.001 0.001 
RPLP0 0.000 0.000 0.000 0.002 0.001 0.000 0.000 
actin 0.000 0.000 0.000 0.001 0.000 0.003 0.000 
β-tubulin 0.001 0.000 0.001 0.001 0.000 0.000 0.001 
PKA 0.001 0.000 0.000 0.000 0.000 0.000 0.000 
GAPDH 0.000 0.000 0.000 0.000 0.001 0.002 0.001 
GST1 0.000 0.000 0.001 0.000 0.001 0.002 0.000 
 
Table 11: Normfinder intergroup variation for all candidate reference genes. 
Gene Larvae Midgut Hindgut Salivary 
glands 
Crop Fat body Nerve 
ganglion 
18S rRNA 0.032 0.018 0.066 -0.053 -0.016 -0.100 0.053 
28S rRNA -0.011 -0.027 0.064 -0.047 0.062 -0.089 0.048 
RPS3 0.028 0.015 0.008 -0.023 0.012 -0.012 -0.028 
EF1α -0.001 -0.001 0.002 -0.028 0.022 -0.024 0.030 
RPLP0 -0.028 -0.009 -0.004 -0.010 0.019 -0.010 0.042 
actin -0.103 0.016 -0.006 0.084 -0.099 0.094 0.012 
β-tubulin 0.055 0.008 -0.069 -0.003 -0.045 0.078 -0.024 
PKA -0.007 0.003 -0.023 -0.028 0.042 0.052 -0.038 
GAPDH -0.004 -0.018 0.011 0.056 0.025 0.006 -0.075 
GST1 0.039 -0.005 -0.047 0.052 -0.023 0.005 -0.021 
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Licenses and copyright 
Figures 1 “Animal species infographic” (according to Chapman (2009)), 7 “MDT treatment of chronic 
wounds”, 8 “UO reaction mechanism”, 11 “Two-step colorimetric UO assay “ (according to Fraisse et 
al (2002)), 19 “UOr expression, purification and refolding”, tables 2, 5, 6, 7, 8 and 9 were created by M. 
Sc. Andre Baumann for the purpose of this thesis. 
Figure 2 “Green_bottle_fly3.jpg “Calibas is licensed under CC-BY-SA 4.0 and thus free to use with this 
attribution. 
Figure 3 “The life-cycle of L. sericata” was designed (according to Grassberger et al. (2013)) and kindly 
provided by Dr. Henrike Schmidtberg. 
Figure 4 “Maggot anatomy” was designed (according to Fleischmann et al. (2004)) and kindly provided 
by Dr. Henrike Schmidtberg. 
Figure 5 “History of maggot therapy” was designed (according to Fleischmann et al. (2004)) and kindly 
provided by Dr. Anne Pöppel. 
Figure 6 “Overview of proven and postulated mechanisms by which medical maggots promote wound 
healing” from Sherman (2014) published in the Hindawi journal Evidence-Based Complementary and 
Alternative Medicine is licensed under CC BY 4.0 and thus free to use with this attribution. 
All the contend used from the Insect Biochemistry and Molecular Biology submission Baumann et al. 
(2016) was created by M. Sc. Andre Baumann. The Elsevier`s “prior publication” policy applies for this 
material, which can thus be published within the journal criteria 
(https://www.elsevier.com/authors/journal-authors/policies-and-ethics). This policy applies to figures 9, 
10, 17, 18, 20, 21, 22, 23 and all text passaged including those used in methods, results and discussion. 
All the contend used from the PLOS ONE article Baumann et al. (2015) is licensed under CC BY 4.0 
and free to use with this attribution. All the  material published within this article was created by M. Sc. 
Andre Baumann. This applies to figures 12, 13, 14, 15, 16, 24, tables 1, 3, 4 10 11as well as all text 
passaged including those used in Methods, Results and Discussion. 
   
Zusammenfassung 
81 
 
Zusammenfassung 
Die Maden-Débridement-Therapie (MDT) ist eine durch die U.S. Food and Drug Administration (FDA) 
und European Medicines Agency (EMA) zugelassene Behandlung für verschiedene chronische und 
hartnäckige Wunden. MDT wurde in zahlreichen Fallstudien erfolgreich angewendet (Sherman 2002; 
Sherman 2003), welche die fördernden Eigenschaften in Débridement, Desinfektion sowieso 
beschleunigter Wundheilung zeigten (Sherman 2014). Maden Sekretions- und Exkretionsprodukte (E/S) 
sind eine komplexe Mischung aus Enzymen, AMPs und niedermolekularen Verbindungen und als 
solches eine reiche Quelle für neue Therapeutika (Sherman 2014). Die Komplexität dieser Mischung 
macht es sehr schwer, die exakte Rolle und die positiven Effekte einzelner Komponenten im 
Heilungsprozess zu bestimmen und macht detailliertere Analysen erforderlich (Davydov 2011). 
Diese Arbeit besteht aus zwei Teilen. Der erste Teil, wie in Baumann et al. (2015) publiziert, hat den 
Schwerpunkt in der Etablierung eines qRT-PCR Ansatzes zur gewebespezifischen Untersuchung der 
Expressionsstabilität von 10 Referenzgen-Kandidaten in Immunisierungs-Experimenten. Quantitative 
RT-PCR ist der Goldstandart im Bereich der Genexpressionsanalyse (Bustin et al. 2009; Nolan et al. 
2006) und seine Etablierung in L. sericata stellt ein wichtiges Werkzeug für die Identifizierung und 
Validierung von Genen, die an der Madentherapie beteiligt sind, dar. Meine Arbeit zeigt, dass die 
Kombination der drei Referenzgene RPLP0, EF1α und RPS3 eine verlässliche Normalisierung von 
L. sericata Expressionsdaten in allen getesteten Proben ermöglicht. Dies erlaubt zum ersten Mal die 
präzise Normalisierung der Genexpression in Madengeweben, welche eine Rolle in der Produktion von 
E/S spielen. Die Methoden zur Bearbeitung von Gewebeproben und zur Genexpressionsanalyse, die im 
Rahmen dieser Arbeit etabliert wurden, haben auch zu den Publikationen Beckert et al. (2015) und 
Beckert et al. (2016) beigetragen. Außerdem fanden die Referenzgene bereits Anwendung in Pöppel et 
al. (2016) und Franta et al. (2016). 
Im zweiten Teil dieser Arbeit, eingereicht als Baumann et al. (2016) (Insect Biochemistry and Molecular 
Biology) wurde die Uratoxidase (UO) von L. sericata heterolog exprimiert und charakterisiert. Dieses 
Enzym erzeugt Allantoin, welches zum Wundheilungsprozess beiträgt (Araujo et al. 2010; DiSalvo 
2002). Ich war der Erste, der eine Insekten UO exprimiert und charakterisiert hat. Das rekombinante 
Enzym wurde in E. coli exprimiert, mittels IMAC unter denaturierenden Bedingungen aufgereinigt, 
rückgefaltet und hinsichtlich pH-Optimum (im Basischen), Temperaturoptimum (20-25 °C), 
kompetitiver Inhibition (typisch für UOs), Kofaktoren (Kofaktor unabhängig) und Stabilität (kurze 
Halbwertszeit) untersucht. Des Weiteren wurde L. sericata UO sowohl auf mRNA- als auch auf 
Proteinebene in verschiedenen L. sericata Geweben lokalisiert. Ich konnte zeigen, dass sowohl die 
UO-mRNA als auch das native UO-Enzym vorwiegend in den Zellen der Malpighischen Gefäße und 
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dort in beiden Fällen strikt zytosolisch lokalisiert ist. Basierend auf diesen Ergebnissen kann 
angenommen werden, dass Allantoin durch UO produziert wird, um Harnsäure aus der 
Insektenhämolymphe über die Malpighischen Gefäße zu entfernen und über den Hinterdarm als 
Stickstoff-Abfallprodukt zu exkretieren. Diese Ergebnisse unterstützen die Hypothese, dass nicht nur 
aktiv sekretierte Moleküle, sondern auch Exkretionsprodukte zu den positiven Effekten der MDT 
beitragen. 
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